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Zusammenfassung 
 
Myxobakterien synthetisieren vielfältige und interessante Sekundärmetabolite mit 
beeindruckenden biologischen Aktivitäten und Wirkmechanismen. Auf der Suche nach 
neuen bioaktiven Verbindungen wurden Proben aus der ganzen Welt mittels 
unterschiedlicher Kultivierungs- und Isolierungstechniken erforscht. Einige neue Isolate 
wurden erfolgreich kultiviert und repräsentieren neue Familien (Phaselicystidaceae) und 
neue Gattungen (Phaselicystis, Aetherobacter, Minicystis, Pseudochondromyces). 16S-
rRNA-Gensequenzanalysen ergaben, dass sie die bisher ‘unkultivierte’ Gruppe von 
Myxobakterien zu vertreten scheinen.  
Bei der chemischen Charakterisierung der neuen Isolate mittels GC-MS-Analyse 
wurden große Mengen mehrfach ungesättigter Fettsäuren (PUFAs) von hohem 
kommerziellem Wert nachgewiesen. Acht PUFAs, die verschiedene ω-3 und ω-6 
Fettsäuren (FAs) umfassen, wurden erstmals in Myxobakterien identifiziert. Bei FA-
Analysen und 16S-rRNA-Gensequenzanalysen erwiesen sich die Myxobakterien 
abermals als einheitliche Gruppe. Diese Feststellung bereitet nicht nur den Weg für die 
chemo-phylogenetische Zuordnung der Myxobakterien, sondern hilft ferner dabei 
potenzielle neue Stämme, die PUFAs produzieren, zu identifizieren. 
Die vorliegende Arbeit hebt auch die Entdeckung neuer bioaktiver Verbindungen aus 
der neuen Art Aetherobacter rufus SBSr003T hervor. Mittels semi-präparativer HPLC-
Auftrennungen wurden zwei neuartige bioaktive Verbindungen gewonnen. NMR-
Analysen ermöglichen derzeit die Strukturaufklärung dieser Verbindungen. Insgesamt 
wurde veranschaulicht, dass Myxobakterien als Modelorganismen für viele 
umfangreiche und vielversprechende Anwendungen dienen können. 
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Abstract 
 
Myxobacteria synthesise diverse and interesting secondary metabolites with impressive 
biological activities and modes of action. In an effort to uncover new bioactive 
compounds, world-wide samples were explored using various cultivation and isolation 
techniques. Several novel isolates were successfully cultivated representing a new 
family (Phaselicystidaceae) and new genera (Phaselicystis, Aetherobacter, Minicystis, 
Pseudochondromyces). Based on 16S rRNA gene sequence analysis, they appear to 
represent the so-far ‘uncultivated’ group of myxobacteria.  
During the chemical characterisation of novel isolates, large quantities of commercially 
valuable polyunsaturated fatty acids (PUFAs) were detected by GC-MS analysis. Eight 
PUFAs, comprising different ω-3 and ω-6 fatty acids (FAs), were identified for the first 
time in myxobacteria. Based on FA and 16S rRNA gene analyses, myxobacteria were 
again proven to be a coherent group. This finding not only pioneers the chemo-
phylogenetic correlation of myxobacteria but also aids in the identification of potentially 
new PUFA-producing strains.  
The study also highlights the discovery of new bioactive compounds in the novel species 
Aetherobacter rufus SBSr003T. Semi-preparative HPLC separations yielded two novel 
bioactive compounds. Ongoing NMR analysis will enable elucidation of the 
compounds’ structures. Overall, myxobacteria were exemplified as model organisms for 
many wide and promising applications. 
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Chapter I. Introduction 
 
Myxobacteria are one of the most fascinating Gram-negative spore-forming prokaryotes. 
They exhibit unique and complex life cycles leading to the formation of multicellular 
fruiting bodies (Shimkets et al., 2006), a structure more commonly attributed to 
eukaryotic fungi. In over 30 years of work on myxobacteria, roughly 7,000 strains have 
been isolated, covering most of the described species and genera (Reichenbach, 2005). 
To date, 53 species of myxobacteria have been validly recognised (Table 1). The 
number of isolates discovered in the past appears to be a reflection of the efficiency of 
cultivation methods derived from standard microbial baiting and biomacromolecule 
degradation. Despite the success of these methods, however, there are still validly 
described myxobacterial strains which remain uncultivated, exemplified by 
Haploangiun and many species of Polyangium (Reichenbach, 2005; Peterson, 1959). 
 
Metagenomic studies based on 16S rRNA gene unveal high similarities of many 
sequences to clones of uncultured bacteria, suggesting that myxobacteria are far more 
diversified than previously thought (Jiang et al., 2007). Their presence in deep sea vents 
(Moyer, et al., 1995), hydrothermal springs (Iizuka et al., 2006), marine samples (Iizuka 
et al.,1998; Iizuka et al., 2003a - 2003b; Li et al., 2002), and fresh water environments 
have also been documented and explored (Jahn, 1924; Hook et al., 1980). Unknown 
nutritional behaviour and metabolism are believed to be the major contributing factors to 
the unsuccessful cultivation of many uncultured myxobacterial strains. 
 
Myxobacteria have gained attention not only for their social and developmental lifestyle 
(Dworkin, 1996; Hoiczyk et al., 2009; Kearns et al., 2001; Reichenbach, 1984) but also 
for their ability to produce diverse secondary metabolites and complex mega-
biosynthetic enzymes (Weissman & Müller, 2010; Wenzel & Müller, 2009; Kopp et al., 
2004; Müller & Gerth, 2006; Reichenbach, 2001). From approximately 7,000 identified 
myxobacterial strains (Gerth et al., 2003; Reichenbach, 2005), around 100 core 
structures and 500 derivatives have been structurally elucidated (Bode & Müller, 2008), 
securing their reputation as one of the premier sources of natural products. Although the  
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Table 1. List of validly described taxa in myxobacteria. 
 
I. Suborder Cystobacterineae  II. Suborder Sorangiineae 
Family Myxococcaceae  Family Polyangiaceae 
Genus Myxococcus (5)  Genus Polyangium (7) 
Myxococcus xanthus    Polyangium vitellinum 
Myxococcus virescens    Polyangium aureum 
Myxococcus fulvus    Polyangium luteum 
Myxococcus stipitatus    Polyangium sorediatum 
Myxococcus macrosporus    Polyangium spumosum 
Genus Corallococcus (2)    Polyangium fumosum 
Corallococcus coralloides    Polyangium parasiticum 
Corallococcus exiguus  Genus Chondromyces (6) 
Genus Pyxidicoccus (1)    Chondromyces crocatus 
Pyxidicoccus fallax     Chondromyces apiculatus 
Genus Anaeromyxobacter* (1)    Chondromyces robustus 
Anaeromyxobacter dehalogenans    Chondromyces catenulatus 
Family Cystobacteraceae    Chondromyces pediculatus 
Genus Cystobacter (10)    Chondromyces lanuginosus 
Cystobacter badius  Genus Sorangium (1) 
Cystobacter armeniaca    Sorangium cellulosum 
Cystobacter violaceus   Genus Byssovorax (1) 
Cystobacter miniatus    Byssovorax cruenta 
Cystobacter minus  Genus Haploangium (2) 
Cystobacter gracilis    Haploangium rugiseptum 
Cystobacter velatus    Haploangium minus 
Cystobacter ferrugineus  Genus Jahnella (1) 
Cystobacter fuscus    Jahnella thaxteri 
Cystobacter disciformis  Family Phaselicystidaceae 
Genus Archangium (1)  Genus Phaselicystis (1) 
Archangium gephyra    Phaselicystis flava 
Genus Stigmatella (3)  III. Suborder Nannocystineae 
Stigmatella erecta  Family Kofleriaceae 
Stigmatella aurantiaca  Genus Kofleria (1) 
Stigmatella hybrida    Kofleria flava 
Genus Melittangium (3)  Genus Haliangium (2) 
Melittangium lichenicola    Haliangium tepidum 
Melittangium boletus    Haliangium ochraceum 
Melittangium alboraceum  Family Nannocystaceae 
Genus Hyalangium (1)  Genus Nannocystis (2) 
Hyalangium minutum    Nannocystis exedens 
(Genus Angiococcus)    Nannocystis pusilla 
Angiococcus disciformis = C. disciformis  Genus Plesiocystis (1) 
     Plesiocystis pacifica 
   Genus Enhygromyxa (1) 
     Enhygromyxa salina 
Total number of species: 53 
* Sanford et al., 2002. 
   Number of validly described species is shown after the generic name. 
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number of compounds discovered in myxobacteria exceeds than the number of 
described species, bioactive compound mining is still far from exhaustion, especially 
after the discoveries of many novel and rare genera from terrestrial and aquatic habitats 
(Ojika et al., 2008; Kunze et al., 2006). In the continuous secondary metabolite 
screening program at the Helmholtz Institute for Pharmaceutical Research (HIPS), 
which has yielded still more novel isolates (Garcia et al., 2010), it is expected that many 
more new scaffolds will be isolated and elucidated in the future.  
 
The potential of myxobacteria does not appear limited to antibiotics and cytotoxic 
compounds; they have also surprisingly been implicated in the production of steroids 
(Bode et al., 2003; Gawas et al., 2011) and recently, in the production of commercially 
important polyunsaturated fatty acids (Stadler et al., 2010), hence making them 
promising model bacteria for many industrial, pharmaceutical, and medicinal 
applications. 
 
Outline of the Study 
 
The study initially focuses on unearthing new myxobacterial producer strains from 
global samples using a combination of microbiological, chemical, molecular, and 
phylogenetic techniques (Garcia et al., 2009a). New approaches for isolation, 
cultivation, and preservation are meticulously described leading to the discovery of 
novel isolates. An improved screening regimen for secondary metabolites, based on a 
combined chemical and biological approach, is also emphasised for the mining of 
interesting compounds from myxobacteria (Garcia et al., 2009a; Krug et al., 2008). 
 
The second part of the work deals with the characterisation of a new myxobacterial 
family (Garcia et al., 2009b), and the proposal of four other strains into new species and 
genera. In addition to morphological and chemo-physiological characterisation, their 
assignments to novel taxa strengthened by molecular and phylogenetic analyses.   
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Another major highlight of this study is the classification and taxonomic assignment of 
the novel isolates and representative type strains through a 16S rRNA-based 
phylogenetic study (Garcia et al., 2010). This involves sequencing of many type-neotype 
strains, verification and correction of previously published sequences, and careful 
analysis of their phylogenetic positions. Sequences of clones previously thought to be 
“uncultured bacteria” were analysed and their possible positions in the phylogenetic tree 
determined. 
 
During the course of chemical characterisation of the novel isolates, unusual fatty acid 
(FA) patterns were detected. Interestingly, diverse polyunsaturated fatty acids belonging 
to omega-3 and omega-6 families were revealed. Findings from the novel isolates’ FAs 
have led this work to further explore and determine the available myxobacterial 
representative type-neotype strains, allowing them to be correlated in the phylogenetic 
tree (Garcia et al., 2011). The analysis was also extended to morphologically-related 
gliding bacteria belonging to Herpetosiphon and Flexibacter. The discovery of PUFAs 
in myxobacteria promises great commercial and biotechnological capability for 
industrial application (Stadler et al., 2010).  
 
Lastly, the work describes the potential of the novel taxa as sources of new bioactive 
compounds. Aetherobacter represents a novel genus in Sorangiineae, which, in this 
study, was mined for novel secondary metabolites. The work encompasses compound 
purification, isolation, and bioassay assesments. 
 
Myxobacterial Natural Products 
Myxobacteria have gained recognition as intriguing sources of new pharmaceutical 
drugs (Mulzer, 2009). The identification of diverse and structurally unique compounds 
has established them as one of the most outstanding secondary metabolite producers 
amongst the prokaryotes (Reichenbach, 2001; Reichenbach & Höfe, 1993, 1999; Gerth 
et al., 2003, Bode & Müller, 2006; Weissman & Müller, 2010). Table 2 shows the 
diversity of compounds amongst myxobacterial taxa. Sorangium (48.4%), 
Chondromyces (10.3%) and Polyangium (5.2%) account for nearly 64% of the currently  
 Chapter I 
5 
 
  
Table 2. Distribution of secondary metabolites amongst myxobacterial taxa. 
 
 
 
(-)    Nothing known so far.  
*      Since it was initially misclassified as “Angiococcus,” thus appear to share the same production. 
 **   Ojika et al., 2008; Iizuka et al., 2006. Not validly described yet. 
        Boldface shows the examples of the overlapping compound amongst suborders. 
        Total number of compound in the family is enclosed in parenthesis. 
        
Taxa Secondary Metabolites Total
Suborder Cystobacterineae   
   Family Cystobacteraceae  (31)
      Genus Archangium archazolid, argyrin, aurafuron, gephyronic acid, germacran, myxovalargin, 
tubulysin, vioprolide 8
                  Cystobacter althiomycin, cyrmenin,  cystothiazole, myxalamide, melithiazol, pyrrolnitrin, 
stigmatellin, vioprolide 8
                  Melittangium  melithiazol, pyrrolnitrin 2
                  Stigmatella aurachin, aurafuron, dawenol, myxalamide, myxothiazol, nitroresorcinol, 
stigmatellin, stigmolone 8
                  Hyalangium - 0
                  (Angiococcus) althiomycin, angiolam, myxocheline, myxothiazol, tubulysin 5
   Family Myxococcaceae  (20)
                  Myxococcus althiomycin, cittilin, Dkxanthene, harman, myxalamide, myxocheline, myxochromide, 
myxopyronin, myxothiazol, myxotyroside, myxovalargin, myxovirescin, phenalamide
(stipiamide), pyrrolnitrin, rhizopodin, saframycin Mx1 16
                  Corallococcus corallopyronin, pyrrolnitrin, myxothiazol, myxovalargin 4
                  Pyxidicoccus * - 0
                  Anaeromyxobacter - 0
Suborder Sorangiineae  
   Family Polyangiaceae  (48)
                  Polyangium phenoxan, thiangazol 2
                  Chondromyces apicularen, ajudazol, chondramide, chondrochloren, crocacin, crocapeptin, 
jerangolid, pedein, thuggacin 9
                  Sorangium ambruticin, carolactone, chivosazol, chlorotonil, disorazol, eliamide, epothilone,
etnangien, eudesmadien, icumazol, invictolid, jerangolid, leupyrrin, maracen,
maracin, pellasoren, pentacaronic acid, phoxalone, pyrrolnitrin, ratjadon, ripostatin, 
socein, sorangicin, sorangiadenosine, sorangiolid, soraphen, soraphinol, spirangien,
spirodienal, sulasoren, sulfangolid, tartrolon, thuggacin, trichangion, tuscolid,
tuscoron 36
                  Byssovorax cruentaren 1
                  Haploangium - 0
                  Jahnella - 0
   Family Phaselicystidaceae  0
                  Phaselicystis - 0
Suborder Nannocystineaea  
   Family Nannocystaceae  (7)
                  Nannocystis geosmin, germacran, nannochelin, phenylnannolone 4
                  Plesiocystis - 0
                  Enhygromyxa - 0
                  ‘Paraliomyxa’ ** miuraenamide 1
   Family Kofleriaceae  (1)
                  Kofleria - 0
                  Haliangium haliangiacin 1
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identified myxobacterial compounds (Gerth et al., 2003), hence making Sorangiineae 
the most efficient source amongst the suborders. Although this group represents only a 
quarter (26%) of the total myxobacteria collection at the HZI (formerly the German 
Centre for Biotechnology - GBF), the compound diversity is overwhelming, predicted to 
soar even higher in the near future after cultivation of many new strains in this suborder 
(Garcia et al., 2010). The numbers will also likely increase as a result of efforts to 
cultivate strains which, at the moment, represent the “unculturable” group (Jiang et al., 
2007; Jiang et al., 2010). 
 
Although there are only a limited number of myxobacterial species known to date 
(Garcia et al., 2010; Reichenbach, 2005), the number of compounds identified has 
reached into the hundreds. The unbalanced ratio between species and compounds 
discovered in myxobacteria can be attributed to the diversity of metabolites produced by 
a single strain. Interestingly, the compounds and their chemical derivatives identified in 
myxobacteria usually belong to different structural classes. The majority of these 
compounds are polyketides, non-ribosomal peptides, or hybrids thereof (Weissman & 
Müller, 2010).  
 
Myxobacterial compounds can also be classified on the basis of bioactivity. The bulk of 
them are antimicrobial; approximately 54% are known antifungals which primarily act 
on the mitochondrial respiratory chain, specifically targeting complexes I and III (Gerth 
et al., 2003). Examples of these compounds are thiangazole, phenoxan, myxalamid, 
myxothiazol, haliangiacin, crocain and miuranamide. Other antifungal compounds 
isolated from myxobacteria disrupt macromolecule synthesis, inhibit cell membrane 
synthesis, and target acetyl-CoA carboxylase. 
 
Antibacterial metabolites produced by myxobacteria account for nearly one-third of the 
total number of compounds isolated from these organisms (Gerth et al., 2003). Modes of 
action are much wider in scope, spanning a large number of different targets. 
Althiomycin, angiolam, and myxovalargin are, for example, inhibitors of protein 
synthesis, while myxoviriscins act on cell wall synthesis. In the case of corallopyronin, 
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etnangien, myxopyronin, ripostatin, and sorangiacin, the eubacterial RNA polymerase 
appears to be the target. Intriguingly, etnangien also appears to act upon DNA 
polymerase. Compounds acting against acid-fast mycobacteria have also been 
discovered, as exemplified by maracin, maracen, and thuggacin; the latter appears to be 
a promising candidate for anti-tuberculosis therapy. 
 
Recent reviews on myxobacterial secondary metabolites have identified 32 major classes 
of cytotoxic compounds (Weissman & Müller, 2010). Most interesting are those 
structural classes targeting the eukaryotic cytoskeleton, which could be encouraging 
leads for future development as anti-cancer drugs. Chondramide, chivosazol, and 
rhizopodin are some of the most interesting cytotoxic natural products specifically 
affecting actin filament formation, while in tubulysin, disorazol and epothilone, tubulin 
appear to be the target. The latter compound has been studied thoroughly (Mulzer, 2009) 
and is being marketed as an anti-cancer drug for breast cancer therapy.   
 
Approach to Novel Strain Discovery 
Myxobacteria are widely distributed in nature, representing all geographical and climate 
zones (Dawid, 2000; Reichenbach, 1999b). In the past decades, the search has covered 
soil samples, herbivores dung, tree bark, and rotting plant materials, yielding diverse 
species, representing different genera and suborders (Reichenbach & Dworkin, 1992). 
Samples collected from living tree bark have also yielded novel species (Peterson, 
1959). Some groups are often isolated from their niches on particular substrate, 
reflecting in their social lifestyle. Myxococcus virescens and Cystobacter fuscus are, for 
example, commonly isolated in rabbit dung while Stigmatella aurantiaca appears 
common in rotting wood bark. The novel genus Jahnella was also discovered colonising 
rabbit dung, suggesting its proteolytic-bacteriolytic nutrition behaviour (Reichenbach, 
2005). In addition, several studies have shown that they can also be isolated from 
alkaline peat bogs (Hook et al., 1980). Samples collected in the desert, Antarctica (Gerth 
& Müller, 2005; Dawid et al., 1988), and even those taken from hot springs have also 
contained myxobacteria (Iizuka et al., 2006). Environments with dynamic interactions of 
organisms and stark competition for common resources, as exemplified by the tropical 
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and subtropical forest, appear to be the most promising source for interesting novel 
strains.  
 
Myxobacteria often inhabit terrestrial environments, growing under aerobic condition. 
The discovery of three novel “halophilic” and anaerobic myxobacteria was surprising. 
Plesiocystis, Enhygromyxa, and Hyalangium, representing the halophilic genera, were 
discovered from a marine environment, or marine-associated samples (Iizuka et al., 
2003a, Iizuka et al., 2003b; Fudou et al., 2002). Halophilic conditions and an 
unexplored sampling environment illustrate the extensive possibilities for isolation of 
new taxa. The oxygen-free condition used in the isolation of Anaeromyxobacter had 
never been attempted before in the isolation of myxobacteria (Sanford et al., 2002) and 
therefore clearly represent a new isolation technique. 
 
In principle, novel myxobacterial strains could possibly be brought into culture in the 
future from unexplored sources by using different methods of isolation and baiting 
techniques. The expectation that the new isolates show unusual characteristics is high, 
thus necessitating a certain familiarity with current biology and taxonomy in order to 
differentiate and recognise them. Swarming and fruiting bodies are characteristics 
commonly observed during the isolation and attention should be devoted to the search 
for these stages. The inability of novel myxobacteria to produce fruiting bodies appears 
possible (Jiang et al., 2007), a consideration that must be kept in mind during isolation. 
 
Myxobacterial phylogeny  
Myxobacteria are a coherent group belonging to the delta Proteobacteria (Woese et al., 
1985; Shimkets & Woese, 1992; Spröer et al., 1999). They are postulated to originate 
from a common ancestor, a hypothesis that is supported by phenotypic, genotypic, and 
molecular features (Kaiser et al., 1993). The group (order Myxococcales) was 
phylogenetically divided into suborders Cystobacterineae, Nannocystineae, and 
Sorangiineae, all of which exhibit gliding characteristic of the vegetative cells. 
Myxobacterial diversity and their phylogenetic position have been documented 
extensively from both marine and terrestrial domains (Brock Neil et al., 2005; Jiang et 
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al., 2007; Jiang et al., 2010; Moyer et al., 1995; Zhang-Cai et al., 2003; Iizuka et al., 
2006). From the 26 previously studied culturable morphospecies (Spröer et al., 1999), 
the number of identified myxobacteria has increased significantly almost doubling in the 
last decade (Garcia et al., 2010). The escalating number of strains appears to be 
associated to advances in sequencing of highly conserved housekeeping genes, so much 
that their phylogenetic position can be clearly verified to allow identification. In 
myxobacteria, for example, lepA, fusA, rpoB, gyrB, and 16S rRNA genes have been 
used for genotypic classification (Stackerbrandt et al., 2007). The latter gene appears to 
be the most widely used and established method, and is therefore commonly chosen for 
phenetic (genotypic and phenotypic traits) studies (Lang et al., 2008; Lang & Spröer, 
2008). 
 
Reports have shown that many clone sequences have high similarity with uncultured 
bacteria, and were phylogenetically determined to cluster with myxobacteria (Jiang et 
al., 2007; Jiang et al., 2010). These clones may possibly represent the viable but not 
culturable (VBNC) organisms. Although myxobacteria are often distinguished by such 
common characteristics as the production of fruiting bodies under starvation conditions, 
a previous study has shown evidence that non-fruiting groups also exist and, appear 
much larger than the known fruiting taxa (Jiang et al., 2007). In addition, the study also 
revealed that the non-fruiting taxa seem to represent the uncultured myxobacteria. 
Myxobacterial diversity in marine environments was also documented and determined to 
be phylogeographically distinct from terrestrial myxobacteria at high levels of 
classification (Jiang et al., 2010). The occurrence of marine myxobacteria seems un-
surprising, as it was previously reported in Pele’s Vents, Hawaii (Moyer et al., 1995). 
 
 
Myxobacterial Fatty Acids: Health Benefits and their Commercial Impact 
Although many studies have dealt with fatty acids of myxobacteria, the majority of them 
have focused on a few select species (Bode et al., 2005). Myxococcus xanthus DK1622 
and Stigmatella aurantiaca DW4/3-1 are the subject of many studies on FAs; however, 
these were concerned with developmental and biosynthetic aspects (Bode et al., 2006a - 
2006b; Dickschat et al., 2005; Ring et al., 2006; Ring et al., 2009). FA analysis has also 
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been widely used in taxonomic characterisation of Corallococcus, Melittangium, and 
other organisms (Lang & Spröer, 2008; Lang & Stackerbrandt, 2009; Monteoliva-
Sanchez et al., 1987; Yamanaka et al., 1988; Kaneda et al., 1991). Previous studies in 
Sorangium require a re-evaluation due to old analytical methods and differences in 
extraction procedures (Fautz et al., 1981). Analysis of FA has also been performed in 
order to differentiate amongst marine isolates and members of the two genera in 
Myxococcaceae (Iizuka et al., 2003a – 2003b; Schäberle et al., 2010; Lang et al., 2008; 
Lang & Stackerbrandt, 2009; Stackerbrandt et al., 2007). In the suborder Sorangiineae, 
only the previously described novel family Phaselicystidaceae has been explored 
thoroughly for FAs (Garcia et al., 2009b). Myxobacteria not only synthesise diverse FAs 
but can also distinguished by characteristic FA types. Some groups are remarkable for 
the absence of hyxdroxy FAs (Iizuka et al., 2003a; Fudou et al., 2002), while some 
contain extraordinary amounts of the iso-branched (iso-FAs) type (Bode et al., 2006), 
which, in Myxococcus xanthus, appears to be involved in the development cycle leading 
to sporulation (Ring et al., 2006). In other bacteria (e.g. Listeria monocytogenes), 
branched-chain FAs play a role in the pH stress tolerance of the organism (Giotis et al., 
2007). 
 
Myxobacteria were surprisingly observed to be capable of polyunsaturated fatty acid 
(PUFA) synthesis. Originally, PUFAs were previously thought to be absent in bacteria 
(Erwin & Bloch, 1964), a hypothesis later disproved through the discovery of some 
PUFA-producing bacterial strains living under high pressure and low temperature 
environments (De-Long & Yayanos, 1986; Nichols et al., 1993; Nichols & McMeekin, 
2002; Yano et al., 1997). Major microbial sources of PUFAs are Schizochytrium, 
Ulkemia, Crytocodinium, and Mortierella (Ward & Singh, 2005). In myxobacteria, the 
halophilic genus Plesiocystis was characterised for the production of long chained C20:4 
fatty acid (Iizuka et al., 2003a), later found in other genera of marine myxobacteria 
(Iizuka et al., 2003b; Schäberle et al., 2010). In terrestrial soil-myxobacteria belonging 
to the genus Phaselicystis, huge amounts of C20:4 FA have been found and identified as 
arachidonic acid (Garcia et al., 2009b). Recently, important omega-3 fatty acids have 
also been discovered in some novel strains of myxobacteria (Stadler et al., 2010). 
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In general, polyunsaturated fatty acids are important and essential components in 
eukaryotic cells, conferring fluidity, flexibility and membrane permeability. 
Eicospentaenoic acid (EPA) has been implicated in cardiovascular health benefits, 
treatment of brain disorders (Fenton et al., 2000; Peet, 2004), and cancer (Tisdale, 
1999), while docosahexaenoic acid (DHA) is associated with eye and brain development 
in infants, and also supports the cardiovascular system. PUFAs are widely and 
commercially used in the market, and are in high demand as supplements in many food 
and dairy products. In infant formula alone, the world wholesale market is estimated to 
be about $10 billion per annum (Ward & Singh, 2005). The growing awareness of the 
health benefits of PUFAs, is expected to significantly contribute to the expansion and 
diversification of market products. Among the major targets for improved commercial 
development of PUFAs are gamma-linolenic acid (GLA), arachidonic acid (ARA), 
docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA).  
 
Discovering Bioactive Compounds in Novel Myxobacteria 
In this study, classical biological screening and modern chemical analytical techniques 
play an important role in the discovery of novel bioactive compounds. Myxobacterial 
cultures for screening are initially grown in small-scale medium containing adsorber 
resins. Myxobacterial compounds are normally stable when they bound to the resins, 
helping in the improvement of yields (Reichenbach, 1999a). Most myxobacteria tolerate 
the presence of XAD-16 in the culture broth without any adverse effect on growth. 
Chemical characterisation of the extracts is routinely performed by HPLC coupled to 
MS, time-of-flight (ToF), high resolution LTQ Orbitrap and tandem MS defined by set 
of parameters. Extracts are simultaneously tested for antimicrobial and cytotoxicity 
using a range of microorganisms and cell line panels (Fig. 1). Extracts exhibiting 
biological activity which cannot be correlated to known masses are further evaluated by 
semi-preparative HPLC fractionation and re-testing against the sensitive organism to 
determine the unknown active compound. A previous study exemplified this approach 
(Garcia et al., 2009a). Target compounds are then marked for large scale fermentation 
after strain improvement and process optimisation (Gerth et al., 2003) and isolation is 
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carried out using a diverse array of analytic and advanced chromatographic separation 
techniques. 
 
a b c
 
 
Figure 1. Example of biological screening of myxobacterial crude extracts. (a) 
Antibacterial test against Gram-positive Rhodococcus opacus, (b-c) Cytotoxicity test 
using potoroo kidney cells (Ptk2) showing nuclear fragmentation (arrows). 
 
 
The novel isolate Aetherobacter rufus SBSr003T vividly illustrates the expectation to 
isolate and identify new metabolites in myxobacteria. After initial identification of 
possible bioactive compounds, screening and isolation process aimed at unearthing the 
novel compounds are described here. Although several more strains were isolated 
representing novel genera and perhaps even a new family, the study is limited only to 
this strain; however, there are future plans to further explore the potential of other novel 
isolates for new and interesting compounds. The discovery of novel myxobacterial 
compounds in this study appears to be undoubtedly and directly associated with the 
discovery of new isolates representing new taxa. 
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Minicystis rosea, gen. nov., sp. nov., a pink myxobacterium  
 
Ronald Garcia and Rolf Müller  
 
 
Running Title: Minicystis: a pink myxobacterium 
 
Subject Category: New Taxa - Proteobacteria 
 
 
 
Abstract 
 
A bacterial strain designated as SBNa008T was isolated from a soil sample collected in 
the Philippines. It exhibits the general characteristics associated with myxobacteria, such 
as swarming of Gram-negative rod-shaped vegetative cells, fruiting body formation, and 
bacteriolytic activity. The strain is mesophilic, chemoheterotrophic, and aerobic. The 
major fatty acids (FAs) are iso−C15:0, C17:1 2-OH and C20:4 ω6, 9,12,15, all cis (AA-arachidonic 
acid). The polyunsaturated omega-3 eicosapentaenoic acid (EPA) was also found. The G 
+ C content of the genomic DNA is 67.3 mol %. 16S rRNA gene sequence reveals 95 – 
96 % similarity to clones of uncultured bacteria, and 94 - 95% to members of 
Sorangiineae. The clustering of the novel isolate to the “unculturables” and its novel 
branch in the phylogenetic tree suggest that SBNa008T represents a novel genus and 
species, proposed here as Minicystis rosea. The type strain for Minicystis rosea is 
SBNa008T (= DSM 24000T, = NCCB 100349T). 
 
Abbreviations:  
FA(s): Fatty acid(s) 
PUFA: Polyunsaturated fatty acid 
AA: Arachidonic fatty acids 
EPA: Eicosapentaenoic acid 
 
 
The GenBank/EMBL/DDBJ accession number for the 16S rRNA gene sequence of 
Minicystis rosea SBNa008T is GU249616. 
 
Reactions to API 32 GN kit are available as supplementary table with the on-line version 
of this paper. 
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INTRODUCTION 
 
The strain was isolated in December 2007 from Philippine soil sample containing plant 
material taken from Landsweiler-Reden collection, Germany. It was recognised as a 
myxobacterium through its swarming and fruiting body characteristics on agar baited 
with live Escherichia coli. Cells glide coherently on agar in a loose swarming pattern at 
the edge of the colony, and via several transfers of this material to a new plate, the novel 
strain was purified and isolated.  
 
Based on fruiting body observations, SBNa008T was initially classified as a member of 
the Nannocystineae suborder. Among the five recognised genera of this suborder, the 
closest resemblance to its tiny ovoid sporangiole was observed with Nannocystis. This 
feature, along with some other remarkable characteristics, was partially described in the 
comprehensive phylogeny of myxobacteria (Garcia et al., 2010). Although the novel 
bacterium shows many similarities with Nannocystis, vegetative cell morphology 
suggested that SBNa008T might be a Sorangiineae-type myxobacterium, leading us to 
further characterise the isolate. 
 
 
METHODS 
 
Isolation and cultivation. Based on swarming of long slender rod-shaped cells and 
fruiting body formation on water agar, Minicystis rosea was identified as a 
myxobacterium. The strain was purified and isolated by cutting the farthest swarm edge 
and transferring it repeatedly onto a lean water agar. During screening of our global soil 
sample collection, we did not encounter this unusually thin and almost transparent 
colony, which is barely recognisable under the microscope. The organism was routinely 
cultivated and maintained in buffered VY/2 medium (Garcia et al., 2009a) and stored at   
-80 °C. 
 
Microscopy and morphological examination. Swarming colonies and fruiting bodies 
were observed under an Olympus SH−ILLB stereoscopic microscope and photographed 
using an Axiocam MRC (Zeiss) camera. Vegetative cell morphology and myxospores 
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were studied using phase-contrast microscopy (Axio-Star, Carl Zeiss). All growth stages 
were observed on solid agar medium, namely water, buffered VY/2, and cVY/2 (VY/2 
containing filtered autoclaved baker’s yeast).  Vegetative cells were also observed in 
clear MD1G medium (Garcia et al., 2010), but with a reduced concentration of MgSO4 
·7H2O (0.05 %).  
 
Microbial predation test. Overnight cultures of Escherichia coli, Psedumonas stutzeri 
(Gram-negative), Micrococcus luteus (Gram-positive), and 36-h-old culture Hansenula 
anomala (yeast) were used as bait in water agar medium. Growth of the myxobacterium 
and bacterial lysis, as indicated by clearing of the streaked bait and swarm spreading, 
were determined after 5-7 days of incubation at 30 °C. 
 
Physiological and biochemical tests. Reaction of vegetative cells to Gram- and Congo 
red stain was determined accordingly. Staining by the latter was performed according to 
McCurdy (1969). The catalase test was performed with a drop of 3.0 % H2O2 on 
vegetative cells. Cellulose degradation was performed using buffered water, VY/2, and 
cVY/2 agar overlaid with both sterile filter paper (2.0 x 1.0 cm) and a drop of cellulose 
powder solution on separate section of the agar. The chitin degradation assay was also 
performed in the same clear media (except VY/2 agar), but with only a drop of chitin 
powder (Sigma) solution. All set-ups were incubated at 30 °C for 1 to 2 weeks.  
 
Growth determination on xylan, skim milk agar (SKM), and milk casein was previously 
described (Garcia et al., 2009b). Biochemical tests were performed using bioMérieux 
API 32 GN kit according to manufacturer’s instructions, but with slight medium 
modifications to support the nutritional requirements of the myxobacteria (0.05 % 
ammonium sulphate, 0.1 % monosodium phosphate, 0.05 % CaCl2·2H2O, 0.05 % 
MgSO4·7H2O). The set-up was incubated at 30 °C for 5-days, and maintained in moist 
environment. 
 
Growth response to pH, temperature, oxygen, and antibiotics. Growth response to 
different levels of temperature and antibiotic resistance was tested in buffered VY/2 agar 
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(Garcia et al., 2009a) supplemented with vitamin solutions (Shimkets et al. 2006). For pH 
tolerance, VY/2 medium was adjusted accordingly. Vegetative cell inocula came from 3-
d old culture grown in TG1 medium (0.3 % Bacto Tryptone, 0.3 % Glucose, 0.025 % 
CaCl2·2H2O, 0.05 % MgSO4·7H2O, pH adjusted to 7.0 with KOH before autoclaving). 
Cell inoculum was adjusted to 1.0 McFarland (bioMérieux) and spotted (10 µL) on the 
agar. Oxygen response was also tested in TG1 medium (10 mL) and incubated under 
stationary conditions. Incubation for all tests was performed for 4 – 7 days at 30 ºC, 
except for the temperature response tests at 18 ºC, 22 ºC (room temperature), and 37 ºC. 
 
Growth response to nitrogen and sugar sources. Nitrogenous and sugar compounds 
used in this study were previously described (Garcia et al., 2009a) and supplemented here 
into water agar.  
 
Fatty acid and G + C content analyses. Cell pellet from actively growing culture was 
obtained from MD1G medium shaken at 160 rpm, 30 °C. Cellular fatty acid extraction 
from samples was performed in duplicates using the fatty acid methyl esters (FAME) 
method and analysed by GC−MS (Garcia et al., 2011). The mol percent DNA G + C 
content of the novel bacterium was determined by HPLC after nuclease P1 digestion of 
the genomic DNA (Shimelis & Giese, 2006; Li et al., 2003).  
 
16S rRNA gene sequencing and phylogenetic analyses. Genomic DNA extraction from 
actively growing culture and amplification of the 16S rRNA gene were prepared 
accordingly (Garcia et al., 2009b). Other myxobacterial 16S rRNA gene sequences used 
in this study, mostly representing the type strains in suborder Sorangiineae, were 
obtained from GenBank. Sequence alignments were performed using the rapid multiple 
sequence alignment based on fast Fourier transform (MAFFT) v.6.814b (Katoh et al., 
2002). Distance matrices between sequences were calculated using the Jukes-Cantor 
model (Jukes & Cantor, 1969). Phylogenetic tree was constructed using the maximum 
likelihood method (PHYML v2.4.5) (Guindon & Gascuel, 2003), and a bootstrap of 1000 
replicates was calculated (Felsenstein, 1985). Phylogenetic relationship was also 
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confirmed using the neighbour-joining method (Saitou & Nei, 1987). All these programs 
are packed in the Geneious Pro 5.0.2 software (Drummond et al., 2010).  
 
RESULTS AND DISCUSSION 
 
Swarm. The film-like colony is barely visible on agar medium (e.g. VY/2, cVY/2 and 
water agar). Culture agar plates needed to be tilted at an angle for it to be seen. A light 
pink colony was observed on VY/2 agar after 1-2 weeks of incubation in a bright 
environment. Unlike other myxobacteria, no radial veins or ripples were found in the 
colony. The cells swarm in a circular pattern but with unstructured or loose colony edges 
(Fig. 1a). In some cases, small flare-like swarms are produced at the colony border, 
reminiscent of some members of Myxococcaceae. In contrast to many Sorangiineae, 
SBNa008T barely penetrates deep into agar and sometimes exhibits only shallow 
depressions. Furthermore, the novel isolate differs from Nannocystis through the absence 
of deep agar holes and excavations.  
 
Vegetative cells. The vegetative cells are phase-dark, long (1.2 x 4.0 – 8.0 μm), slender 
rods with blunted ends (Fig. 1b), typical of members of the suborder Sorangiineae and 
Kofleriaceae. In liquid medium (e.g. MD1G), vegetative cell clumps appear light peach 
to rose pink.  
 
Fruiting body. Fruiting bodies are composed of tiny spherical to ovoid sporangioles (4.0 
– 12.0 μm diameter), arranged solitarily or as clusters (Fig. 1c). Dense clusters commonly 
developed on agar surfaces, especially close to the centre of the colony. In water agar 
containing a streak of live E. coli, a thin layer of sporangioles matted on lysed bait. 
Although Nannocystis was also able to form small fruiting bodies, large sporangioles 
(40.0 x 110.0 μm) were seen (Reichenbach, 2005). Nannocystis pusilla is unique for its 
uniformly tiny sporangioles (8.0 – 15.0 μm). To date, it appears that M. rosea may be one 
of the smallest sporangiole-bearing myxobacteria, which may be the reason it has been 
undetectable in the past. The novel bacterium was also remarkably different from 
Nannocystis in its ability to form fruiting bodies on the surface of solid medium; the latter 
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commonly developed deep into corroded agar (Reichenbach, 2005). Unlike Polyangium, 
Cystobacter, and Kofleria, which have tightly packed fruiting bodies, the novel isolate 
exhibited more loosely arranged sporangioles. Its absence of sorus enclosing the bunch of 
sporangioles distinguishes them from Sorangium. The tiny fruiting body of SBNa008T 
which is often barely detectable might in some instances be mistaken for encysted 
amoebae. 
 
Myxospores. The myxospores of SBNa008T are phase-dark, slender fat rods measuring 
1.2 x 2.0 – 3.0 μm, with dark granules at the poles (Fig. 1d). These features are typical for 
Sorangiineae. Although Nannocystis appears to be closest morphological relative to 
SBNa008T, their myxopores and vegetative cells differ. Nannocystis is distinct for its 
almost rounded myxospores enclosed in small sporangioles, and produces short rod-
shaped vegetative cells (sometimes almost cuboidal) without clearly evident dark granule 
formation at its poles. 
 
Physiological and biochemical characteristics 
 
Staining characteristics and temperature tolerance. The novel strain was Gram- and 
Congo-red negative. The latter stain confirms that SBNa008T does not belong to the 
suborder Cystobacterineae. Optimal growth was observed at 30 °C, while minimal 
growth was observed at 18 °C and at 37 °C. The latter incubation showed the most 
evident agar depression among the temperatures tested. No growth was observed at above 
37 °C. Colonies appeared transparent to lightly pink coloured on agar, a trait that appears 
common in many myxobacteria when incubated in a bright environment. In some 
myxobacterial genera, carotenoids appear to be responsible for the pigments (Jansen et 
al., 1995; Reichenbach & Kleinig, 1971), although it may also be attributed to some 
secondary metabolites (Ohlendorf et al., 2008; Trowitzsch-Kienast et al., 1993) 
 
pH and oxygen tolerance. SBNa008T exhibited wide pH tolerance from 5.0 – 8.5.  
Optimal growth, represented by colony diameter, was found between pH 7.0 – 8.0 in 
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VY/2 agar. No growth was observed at pH 4.0 and beyond 9.0. Growth was film-like on 
the sides of the test tube, suggesting aerotolerant or facultative behaviour. 
 
 
Figure 1. Growth stages of Minicystis rosea SBNa008T. (a) Swarm colony on agar 
surface, (b) Phase-dark vegetative cells, (c) Clusters of tiny fruiting bodies and cellular 
aggregations, (d) Myxospores released from sporangioles (encircled). Photos taken under 
dissecting- (a, c) and phase-contrast- (b, d) microscope. Bar, 3.75 mm (a), 1.0 mm (c), 
10.0 μm (b, d).  
 
Degradation of biomacromolecules, reaction to different biochemicals, and 
predatory ability. Filter paper, cellulose, and chitin powder solution were not degraded, 
indicating non-cellulolytic and non-chitinoytic behaviour. Xylan was also not degraded. 
Unlike Nannocystis, the novel isolate only exhibits slight depressions on solid medium, 
often found close to the centre of the colony, which suggests weak agar degradation.  No 
growth was also observed in skim milk agar (SKM). Supplementary table S1 shows the 
results of different biochemical tests. 
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The predatory lytic behaviour of the novel isolate to live microbial bait was only 
observed with Gram-negative bacteria, such as Escherichia coli DH10B. At later stages 
of growth, cell aggregation and fruiting bodies developed on the lysed bait. Pseudomonas 
stutzeri, Micrococcus luteus, and Hansenula anomala were not cleared, implying its 
selectivity to lyse and out-comfit them. 
 
Sugar sources. SBNa008T grew well in the presence of soluble starch, fructose, 
saccharose, molasses, and lactose. Poor growth was observed in the same medium 
supplemented with maltose, D-glucose, xylose, sorbitol, D-galactose, arabinose, and 
mannose. In agar containing 0.35 % soluble starch, no clear halo was produced in the 
colony after flooding with iodine solution, suggesting its non-hydrolysis.  
 
Nitrogen and peptone sources. Swarming cells were observed in the presence of 
potassium nitrate and aspartic acid. Better growth was exhibited on the latter substrate, 
but with more scattered migrating cells. No evident colony swarming was observed upon 
incorporation of glutamic acid, urea, and potassium nitrate into the medium.  
 
Best swarming, as reflected by the colony diameter, was seen in medium supplemented 
with peptone and neopeptone. Poor growth was observed in casitone, casamino acids, 
peptone, tryptone, and phytone. 
 
Antibiotic resistance. Minicystis rosea was resistant to apramycin, gentamycin, 
neomycin, and spectinomycin. Poor swarming was observed in tobramycin, while no 
growth was found on ampicillin, carbenicillin, kanamycin, oxytetracycline, streptomycin, 
tetracycline, and rifampicin, indicating its sensitivity.  
 
Fatty acid characteristics. Major fatty acids of M. rosea were iso-C15:0, C17:1 2OH, and 
C20:4ω6 (arachidonic acid) (Table 1). Low amount of omega-3 FA C20:5ω3 (EPA) and trace 
amounts of omega-6 FA C18:3ω6 (GLA - γ linolenic acid) were also detected. 
Polyunsaturated fatty acids appear to be rare in prokaryotes (Nichols et al., 1999; Nichols 
& McMeekin, 2002), but myxobacteria are quite well-equipped to synthesize them. To 
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date, the production of EPA has been correlated to only a few genera of myxobacteria 
(Garcia et al., 2011; Stadler et al., 2010), whereas AA is far more common among the 
Sorangiineae and Nannocystineae suborders (Garcia et al., 2011).  
 
The presence of C17:1 2OH FA supports the clustering of the novel isolate to Sorangiineae, 
simultaneously disqualifying it as a member of Nannocystineae. The latter suborder is 
hallmarked for the absence of hydroxy FA (Garcia et al., 2011). A predominance of 
straight-chain FA over the branched-chain type further supports the affiliation of 
SBNa008T to Sorangiineae. 
 
Table 1. Fatty acid characteristic of Minicystis rosea SBNa008T. 
 
 
* Major fatty acids (> 10 %) are marked in boldface. 
 
 
Fatty acids (FAs) Percent* 
Straight-chain   
C13:0  0.16 
C14:0  0.08 
C15:0  0.56 
C16:0  1.98 
C17:0 1.76 
C18:0  2.23 
C17:1 2-OH  17.27 
C16:0 OAG  0.43 
C18:3ω6 (GLA) 0.19 
C20:4ω6 (AA) 14.18 
C20:5ω3 (EPA) 4.18 
unknown FA 6.63 
Branched-chain   
iso-C14:0  0.11 
iso-C15:0  27.28 
iso-C16:0 0.94 
iso-C17:0 3.17 
iso-C17:0 2-OH  0.08 
iso-C15:0 DMA 13.61 
iso-C15:0 OAG 5.14 
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16S rRNA gene and phylogenetic analysis. 16S rRNA gene sequence of the novel 
bacterium shows 95% similarity to Byssovorax cruenta (AJ833647) and 94% to 
Phaselicystis flava (EU545827), Chondromyces lanuginosus (FJ176774), and Sorangium 
cellulosum (AM746676). 95-96% similarity to clones of uncultured environmental 
bacteria (EU662572, EU104167, AM490752) was also observed. The clustering of M. 
rosea to these clones in the phylogenetic tree suggests that it represents the “uncultured” 
taxon of myxobacteria. This finding is unsurprising after the discovery of several other 
novel myxobacterial isolates also showing close similarity to them (Garcia et al., 2009a; 
Garcia et al., 2010).  
 
Phylogenetic analysis reveals the alliance of SBNa008T to Sorangiineae, forming a 
monophyletic cluster closely related to the “unculturables” (Fig. 2). A previous study, 
covering more than hundred strains, in the expanded phylogeny of myxobacteria supports 
its phylogenetic positioning (Garcia et al., 2010).  
 
Figure 2. Phylogenetic position of Minicystis rosea SBNa008T and its clustering with 
clones of unculturable bacteria (CUB). The tree was constructed based on 16S rRNA 
gene sequences using the maximum likelihood method (PHYML). The numbers at 
branch points indicate the percentage bootstrap support based on 1000 resamplings. 
Values greater than 60 % are shown. Bar, 0.05 substitution per nucleotide position. 
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Description of Minicystis, gen. nov., Garcia and Müller  
Minicystis: Mi.ni.cys'tis. L. comp. minor -us, less, smaller inferior; Gr. fem. n. kustis 
(Latin transliteration cystis), the bladder, a bag; N.L. fem. n. Minicystis, intended to mean 
that the sporangiole size is smaller than those of Nannocystis. 
 
Soil myxobacterium. Vegetative cells are long and cylindrical rods with blunt ends; 
movement occurs by gliding on agar surface. Swarm is thin, transparent, exhibits a non-
distinct radial vein pattern, and is non-adsorbent to Congo red. Colony edges with loose 
migrating cells; agar partially depressed. Myxospores are non-refractive, phase-dark, 
cylindrical slender rods shorter than vegetative cells, and enclosed in sporangial wall. 
Fruiting bodies appear as small, ovoid sporangioles. Bacteriolytic type, does not degrade 
cellulose or chitin. Phylogenetic analysis based on 16S rRNA gene sequence shows 
clustering with Sorangiineae. Type species: Minicystis rosea. 
 
Description of Minicystis rosea, sp. nov., Garcia and Müller  
rosea: ro'se.a. L. fem. adj. rosea, rose-coloured, rosy. 
 
Exhibit all characteristics of its genus. Vegetative cells are fat rods, 1.0−1.5 x 3.5−10.5 
μm in size and phase-dark. Swarms are composed of scattered loose cells, sometimes 
with flame-like extensions at the colony edge, and produced shallow agar depressions. 
Fruiting bodies are composed of tiny sporangioles (20.0 – 49.0 x 25.0 – 56.0 μm), 
typically as monolayered clusters (32.0 – 86.0 x 52.0 – 193.0 μm). Myxospores are non-
refractive, phase-dark, stout and short rods (1.0 – 1.2 x 3.2 – 4.0 μm) with rounded ends, 
enclosed in sporangial wall. Bacteriolytic nutritional type. Mesophilic, aerotolerant or 
facultative anaerobe. Cellulose and chitin not degraded. Good growth in saccharose, 
fructose, mannose, and arabinose. Resistant to apramycin, gentamycin, neomycin, 
spectinomycin and tobramycin. Sensitive to ampicillin, carbenicillin, kanamycin, 
oxytetracycline, tetracycline, streptomycin, and rifampicin. Major cellular fatty acid 
components are iso−C15:0, C17:1 2−OH and arachidonic acid. Mol percent G + C content is 
67.3.  
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The type strain is SBNa008T (= DSM 24000T = NCCB 100349T), isolated in December 
2007 from Philippine soil sample taken from Landsweiler-Reden collection, Germany.  
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Supplementary Table S1. Biochemical characteristics of Minicystis rosea SBNa008T 
obtained from API ID32GN kit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Positive sign indicates growth, negative indicates no growth 
 
 
 
 
 
 
 
Substrates Reaction * 
L-rhamnose + 
N-acetyl-glucosamine + 
D-rhibose + 
Inositol + 
D-saccharose + 
itaconic acid + 
suberic acid + 
sodium malonate + 
lactic acid + 
L-alanine + 
potassium 5-ketogluconate + 
Glycogen - 
3-hydroxybenzoic acid - 
L-serine + 
D-mannitol + 
D-glucose + 
Salicin - 
D-melibiose - 
L-fucose + 
D-sorbitol + 
L-arabinose + 
propionic acid + 
capric acid - 
valeric acid + 
trisodium citrate + 
L-histidine + 
potassium 2-ketogluconate + 
3-hydroxy butyric acid + 
4-hydroxy benzoic acid + 
L-proline - 
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rediscovery of ‘Chondromyces catenulatus’ Thaxter 1904 
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Abstract 
 
A bacterial strain designated as SBCm007T was isolated from decaying dried wood 
material collected in the Wuyishan Nature Reserve, Fujian Province, China. The 
organism was unique in its elegant hanging chain of sporangioles arising from a slender 
stalk, and at the same time for producing sporangioles deep in the agar, suggesting 
dimorphic fruiting body morphology. The sporangioles contain short rod myxospores 
and, after inoculation onto agar, burrowing swarms composed of Gram-negative rod-
shaped vegetative cells were produced. The strain also exhibits both bacteriolytic- and 
cellulolytic-type of nutrition. SBCm007T is classified as mesophilic, aerobic to 
microaerophilic, chemoheterotrophic, and with narrow resistance to various antibiotics. 
Major fatty acids are straight chain C16:1ω7c, C18:1ω9c, and C16:0. The 16S rRNA gene 
sequence shows closest similarity to Sorangium cellulosum strains (96 %), 
Chondromyces apiculatus, and C. lanuginosus (each 95 %). Morphological 
characteristics suggest that SBCm007T represents the myxobacterium described by 
Thaxter (1904), and documented photographically by McNeil and Skerman (1972) as the 
uncultured Chondromyces catenulatus. However, phylogenetic and chemo-physiologic 
analyses strongly support its classification as Pseudochondromyces catenulatus gen. nov., 
sp. nov.  
 
 
Abbreviations: 
FA: Fatty acid 
FAME: Fatty acid methyl esters 
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The GenBank/EMBL/DDBJ accession number for the 16S rRNA gene sequence of 
SBCm007T is GU249617. 
 
Further images of various growth phases of strain SBCm007T and biomacromolecule 
degradation are available as supplementary material with the online version of this paper. 
 
 
INTRODUCTION 
 
Chondromyces is a rod-shaped Gram-negative myxobacterium, often mistaken as fungus 
for its miniature tree-like fruiting body. This genus has one of the largest fruiting bodies 
in myxobacteria visible to the naked eye, and has a microscopically striking stalk and 
sporangiole clusters. Its morphological complexity varies among species, which are 
identifiable by their unique shape and sporangiole arrangement, such as the turnip- and 
bell-shaped appearances of Chondromyces apiculatus and C. pediculatus, respectively. 
 
To date, six species of Chondromyces are validly described (Reichenbach, 2005), though 
only five are included in the approved list of bacterial names with standing nomenclature 
(http://www.bacterio.cict.fr/alintro.html#c). These species represent the neotype strains in 
the open collection (Reichenbach, 2006), except for C. catenulatus. 
 
Thaxter (1904) first discovered C. catenulatus from a rotten poplar log near Hannover in 
New Hampshire, U.S.A. He described the fruiting body as showing a remarkable 
resemblance with the higher imperfect fungi. C. catenulatus is peculiar for its chain 
arrangement of the sporangioles. Unfortunately, the species was only obtained once 
despite all attempts to cultivate in various media. At present, Thaxter’s type specimen TC 
4517T is housed in the Farlow Herbarium, Harvard University, Cambridge, MA, U.S.A. 
(Reichenbach, 2005) but unfortunately cannot be grown. The absence of available live 
type specimen in the culture collection renders this study to describe completely the novel 
bacterium.  
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The second occurrence of C. catenulatus was reported after almost eight decades in 
Southeast Queensland, Australia (McNeil & Skerman, 1972). Scanning electron 
photomicrographs of the fruiting body taken from the natural wood substrate shows the 
characteristic chain sporangiole arrangement. However, no details were given to further 
describe the bacterium. Since then, C. catenulatus has not been found again for almost 40 
years. In both reported occasions, it was never successfully cultivated, and the species 
description relied on Thaxter’s observation in crude culture, yet it was still included in the 
approved list of bacterial names due to its inclusion in the 8th edition of Bergey’s Manual 
of Determinative Bacteriology (Skerman et al., 1980). 
 
The intensive search for myxobacteria in the past decades has yielded more than 7000 
isolated strains (Reichenbach, 2006). Another group has spent 18 years on worldwide 
isolation of myxobacteria, covering 64 countries and representing all geographical 
locations (Dawid, 2000). Despite their efforts, C. catenulatus was never encountered and 
is thus thought to be rare (Reichenbach 2005). We describe here the isolation and 
characterisation of strain SBCm007T. Evidence for its transfer from Chondromyces to a 
proposed novel genus (Pseudochondromyces) is hereby presented. 
 
METHODS 
 
Myxobacterial isolation, purification, and cultivation. Strain SBCm007T was isolated 
in August 2008 from a piece of decaying wood collected along the riverbank in 
Wuyishan Nature Reserve. The sample was air dried after collection and stored at room 
temperature. Enrichment was prepared from mineral salts agar (Shimkets et al., 2006) 
overlaid with two 7.5 x 15mm filter paper strips, and inoculated with 1 – 2 small pieces 
of decaying wood sample. Purification and culture maintenance was performed in VY/2 
buffered yeast agar (Garcia et al., 2009a).  
 
Morphological observations. Growth stage morphology observations were according to 
the described methods (Garcia et al., 2009b). To further evaluate the fine structure of the 
fruiting body and its developmental stages without drying, an environmental scanning 
electron microscope (ESEM, FEI Quanta 400 FEG) was used in wet conditions (ESEM 
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mode). A small part of the agar containing the fruiting body was excised and mounted on 
an aluminum stub. The sample was then cooled down to 276 K and imaged with 
secondary electrons (GSED detector) at 800 Pa, and with an accelerating voltage of 10 
kV. At these conditions samples were stable for several hours. 
 
Physiological tests. Reactions of vegetative cells to Gram and Congo Red stains were 
determined; staining with the latter was according to McCurdy (1969). Catalase test was 
performed with 3.0% H2O2. Cellulose degradation was performed using buffered VY/2 
agar overlaid with filter paper (2 x 1cm), and water agar containing drop of powdered 
cellulose solution. Degradation assay for chitin was done using CT6−, CT7− agar 
(Reichenbach, 2006). Agar degradation was tested by inoculation of the actively growing 
vegetative cells on VY/2 and water agar medium containing 1.0 – 2.0 % Bacto agar. 
 
Microbial predation tests. Overnight cultures of Escherichia coli, Pseudomonas 
stutzeri, Micrococcus luteus, Bacillus subtilis, and 36-h-old yeasts Hansenula anomala 
and Saccharomyces cerevisiae were spot-inoculated (approximately 10 mm in diameter) 
on buffered water agar. These microbial baits were air-dried before inoculated with 
SBCm0007T at the edge of the plate. Cultures were then incubated at 30ºC for one week 
and checked daily for clearing of the baits, indicating lytic activity.  
 
Growth responses to temperature, pH, antibiotic sensitivity, and effect of sugars and 
nitrogen compounds. Tests for growth responses at different levels of temperature, and 
antibiotic resistance were performed in buffered VY/2 agar. For pH tolerance tests, VY/2 
medium was adjusted accordingly. Vegetative cell inocula came from liquid versions of 
the same medium taken from an overnight culture. Tests for nitrogen and sugar utilisation 
were previously described based on CM agar (Garcia et al., 2009a). Incubation for all 
tests was performed for 4 – 7 days at 30ºC, except for temperature response tests at 18ºC 
and 37ºC. Also tested were milk casein and skim milk agar (Garcia et al., 2009a). 
 
Fatty acid and G + C content analyses. Cell pellet from actively growing culture was 
obtained in VY/2 medium, which consequently turned clear after a day of shaking 
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incubation (160 rpm, 30 °C). Cellular fatty acid extraction from duplicate samples was 
performed using the fatty acid methyl esters (FAME) method, and analysed by GC−MS 
(Garcia et al., 2011). The mol percent DNA G + C content of the novel bacterium was 
determined by HPLC after nuclease P1 digestion of genomic DNA (Li et al., 2003; 
Shimelis & Giese, 2006). 
 
16S rRNA gene sequencing and phylogenetic analyses. Genomic DNA extraction from 
actively growing culture and amplification of the 16S rRNA gene was done as described 
(Garcia et al., 2009b). Other myxobacterial 16S rRNA gene sequences used in this study, 
mostly representing the type strains in the suborder Sorangiineae, were obtained from 
GenBank. Sequence alignments were performed using Clustal W, version 2.0 (Larkin et 
al., 2007). Distance matrices between sequences were calculated using the K80 model 
(Kimura, 1980). A phylogenetic tree was constructed using the PHYML v2.4.5 maximum 
likelihood method (Guindon & Gascuel, 2003), and bootstrap of 1000 replicates was 
calculated (Felsenstein, 1985). Phylogenetic relationships were also confirmed using the 
neighbour-joining (Saitou & Nei, 1987) and MrBayes (Huelsenbeck & Ronquist, 2001) 
methods. These programs are packed in Geneious Pro 5.0.2 software (Drummond et al., 
2010). 
 
RESULTS AND DISCUSSION 
 
Isolation and purification. After almost two weeks of incubation, the strain was 
observed to form tree-like fruiting bodies arising from decaying bark inoculum in mineral 
salt agar. The bacterium had also colonised onto the surrounding filter paper, as marked 
by the appearances of fruiting bodies and aggregates of cells. Macroscopically, 
SBCm007T fruiting bodies are visible to the naked eye as orange spots on substrate, and 
exhibiting typical Chondromyces appearance. By plucking the sporangiole hanging at the 
tip of the chain using a fine sterile glass needle and inoculating them onto filter paper 
overlaid on buffered yeast medium, SBCm007T was brought into cultivation. After 3 – 4 
days, swarms in the agar were produced, and subsequent transfers from the colony edge 
allowed the bacterium to be isolated for the first time after more than a century. 
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In two occurrences of C. catenulatus (Thaxter, 1904; McNeil & Skerman, 1972), 
including SBCm007T, both occurred on wood, which appears to be their common 
ecological niche. Based on its first discovery in Hanover, New Hampshire, 
(geographically bordering the Vermont river), and present isolation taken from riverbank 
in Wuyishan, it appears that C. catenulatus is associated with a high water content or 
moist environment. This characteristic correlates with its ability to grow well into soft (< 
1%) agar and in liquid broth medium. 
 
Morphological and cultural characterisations 
 
Swarm. In buffered VY/2 or water agar, pseudoplasmodial swarms with characteristic 
band-shaped end were produced deep in the agar (Fig. 1a). These were typically pale to 
orange in colour. The same pattern was also observed in nutrient free medium (buffered 
water agar). Deep and long agar corrosion was architecturally engraved by the migrating 
cells (Supplementary Fig. S1a). These characteristics are reminiscent of Polyangium 
swarming (Supplementary Fig. S1b).  
 
A long orange fan-shaped pseudoplasmodium swarm was observed on filter paper 
overlaid on water, and VY/2 agar (Garcia et al., 2010). This pattern fits to the description 
of Chondromyces catenulatus (Thaxter, 1904), and finds a counterpart with Byssovorax 
cruenta which also produced this type of swarming on agar but not on filter paper 
(Reichenbach et al., 2006). The presence of wrinkled parchment-like slime trails on filter 
paper differentiates the latter from P. catenulatus. After the colony of SBCm007T reaches 
the end of the paper, or when it comes in contact with agar, the bacterium penetrates into 
the medium, developing band-shaped swarming.  
 
A light peach coloured diffusing pigment around the colony was produced in mineral 
salts agar, becoming even more intense upon supplementation with maltose. No 
fluorescence was observed in and around the colony at both short and long UV 
wavelengths.  
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Vegetative cells. Vegetative cells were slender fat rods (1·2 − 1·4 x 5·0 − 15·0 μm) with 
blunted ends, and phase-dark (Fig. 1b). Members of the suborder Sorangiineae and most 
of the Nannocystineae have these characteristics. In old culture, several refractile rounded 
vesicles (< 10) were observed inside the cell, perhaps fat globules. Motility was by 
gliding in solid substrate. 
 
Myxospores. The myxospores are slightly optically refractile fat rods, measuring half the 
size of the vegetative cells (3 – 7 μm x 1.2 – 1.3 μm), with blunted ends (Fig. 1c), and 
containing dark spots at the ends. The average length of the spores ranged from 4 – 6 μm. 
They are dormant and desiccation-resistant.  
 
Fruiting body. The multicellular organisation of the SBCm007T fruiting body includes a 
stalk and cluster of chain of sporangioles (Fig. 1d). These tree-like features appear 
common only to Stigmatella in Cystobacterineae and Chondromyces in Sorangiineae. Its 
difference to Stigmatella is mirrored morphologically in the vegetative cells, swarm, and 
myxospores. Stigmatella exhibits fusiform vegetative cells with pointed ends, radial 
swarming with flame-like edges, and irregular curved rod myxospores. The novel isolate 
is strikingly different to other Chondromyces species by its chain arrangement of 
sporangioles, which so far has only been observed in C. catenulatus. Overall, the 
SBCm007T fruiting body shows closest morphological similarity to Chondromyces . 
 
P. catenulatus fruiting body is composed of three to five oval sporangioles in a chain, 
with four (125 – 175 μm) being the most common. Two sporangioles are often observed 
in smaller fruiting bodies. The number of sporangioles described by Thaxter (1904) was 
more than double (10 or 12) of that found for SBCm007T. This may depend on the 
number of cells that cooperatively aggregate during morphogenesis, and is perhaps 
influenced by the nutrient source present in the sample material. As noted before, C. 
catenulatus was described based on its appearance on a piece of wood, which seems to 
provide good growth conditions for supporting longer sporangial chains. The fruiting 
body is usually composed of 50 or more chains of sporangioles and appears as an 
inverted broom. The bifurcation of the sporangiole chain, as described by Thaxter, 
 Chapter II 
38 
 
(1904), is somewhat rare, and only noticeable in long chains. However, this 
developmental phenomenon appears to be a consequence of chains merging which occurs 
during sporangiole elongation, and usually results in large fruiting bodies. 
 
 
 
 
Figure 1. Growth morphology stages of Pseudochondromyces catenulatus SBCm007T. 
(a) Swarm colony in agar, (b) Vegetative cells, (c) Myxospore stage, (d) Fruiting bodies 
on crude culture (wood).  Dissecting photomicrographs (a, d), phase-contrast images (b-
c). Bar. 250 μm (a), 10 μm (b, d).  
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Sporangioles show a pale yellow or peach colour during early stage of fructification and 
become yellow-orange at maturity. Its shape varies from oval to spherical, depending on 
its location in the chain. Often, the smallest and spherical sporangioles (22.5 x 25 μm) are 
located at the end or tip of the chain, while the largest appear closest to the stalk. The size 
of sporangioles (20 – 50 x 18 μm) is in agreement with Thaxter (1904). Figure 2 and 3 
show these developmental stages on agar surface. A discovery of spherical masses with 
an enclosing wall in the agar is suggestive of sporangiole (Supplementary Fig. S2). They 
are commonly arranged solitarily or in clusters, containing slightly refractile rod-shaped 
cells with blunted ends. Their desiccation resistance and germination ability leading to 
swarm formation was indicative of myxospores.  
 
A slime thread-like structure, or ‘isthmus’ (5.0– 7.5 x 37.5μm), connects to the stalk and 
between sporangioles in a chain (Supplementary Fig. S3). Sometimes they fused at the 
stalk end to produce a flower-like arrangement of the sporangioles. We did not find a 
chain connected by an alternating series of sporangiole and isthmuses, as those illustrated 
by Thaxter (1904) in his schematic diagram of C. catenulatus (Plate 26, No. 4). 
Occasionally, a white spine attached to the hanging-end sporangiole can be found. 
 
A stalk supporting the chain of sporangioles was not only observed in crude culture, but 
nevertheless could be found axenically (Supplementary Fig. S4). In some instances, 
several of them may develop over time in a specific site to form clusters of fruiting 
bodies. This condition seems to be illustrated well in Figure 2 of Thaxter’s Plate 26 
(Thaxter 1904). At an early stage, the stalk appears to be white and later becomes 
yellowish-brown. The stalk conforms to Thaxter’s description of cytosphores, broad at 
the base and narrow at the tip.  
 
Atypical fruiting bodies of some other species, for example Chondromyces crocatus, may 
also exhibit chain arrangement of sporangioles (Reichenbach, 2005); however they are 
shorter and composed only of a few chains devoid of isthmus. The novel isolate can also 
be differentiated significantly in other features, such as swarm, chemo-physiology, and 
genetic characteristics. 
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Figure 2. Fruiting body developmental stages of SBCm007T on agar medium. (a) mound formation of vegetative cells, (b-d) 
differentiation to ridges of cells and upliftment by stalk development. (e-f) transformation to globular knobs. (g) knob cell elongation 
and cleavage (h) differentiation to chain of sporangioles. Bar, 100 μm.  
 Chapter II 
41 
 
 
Figure 3. ESEM photomicrographs of P. catenulatus fruiting body development (a) 
Humped cellular aggregations. (b) Cellular mass elevation (c) Differentiation into 
developing sporangioles and stalk. (d). Chain of sporangiole development. 
 
Physiological characteristics 
Staining and lytic property. The vegetative cells are Gram-negative and catalase-
positive. The actively migrating swarm cells were Congo-red negative, as is typical 
among suborder Sorangiineae. 
 
Temperature and pH responses. On buffered VY/2 agar, optimal growth was observed 
at 30 °C. Minimal growth could also be observed at room temperature (23 °C) and at     
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33 °C. No growth could be seen at 18 °C and 37 °C. SBCm007T exhibited pH tolerance 
of 5.0 – 8.0. Optimal growth was found at pH 7.0 in VY/2 agar. No growth was observed 
at pH 4.0 and beyond 8.0. 
 
Degradation of biomacromolecules and predatory ability. Chitin and xylan were not 
degraded. No growth was observed in SKM medium. Agar was deeply corroded, splited 
and liquefied (Supplementary Fig. S5); the effect was especially obvious at an agar 
concentration of less than 1.5 %. In our years of experience with myxobacteria, we have 
not found a strain with such strong agarolytic characteristic as SBCm007T. A closer 
similarity, but to a lesser degree, was found among members of the Polyangium, which 
upon incubation form soft and watery agar. 
 
Lysis of live microbial bait was observed in Gram-negative Escherichia coli and 
Pseudomonas stutzeri. Gram-positive Bacillus subtilis was also lysed, but not 
Micrococcus luteus, or yeast (Saccharomyces cerevisiae, Hansenula anomala). The 
predatory behaviour of SBCm007T is perhaps attributed to its lytic enzymes and bioactive 
compounds, which myxobacteria have become famous for. 
 
Filter paper was slowly degraded (Supplementary Fig. S6a). To date, this is the third 
group of myxobacteria discovered after Sorangium and Byssovorax, capable of cellulose 
breakdown (Supplementary Fig. S6b-c).The novel isolate pulls apart the cellulose fiber 
strands and eventually degrades them (Supplementary Fig. S6d). Filter paper strips 
become smaller, leaving imprints of border edges on the agar (Supplementary Fig. S6e). 
The strain was initially suspected to be a cellulose degrader when it grew well on a lean 
medium (Water agar) with only filter paper as the carbon source. The degradation process 
usually takes more than 3 weeks of incubation on filter paper overlaid on agar. In 
Sorangium, we observed strong and complete cellulose degradation, with fiber strands 
filled with chains or clusters of fruiting bodies (Supplementary Fig. S6b). In Byssovorax, 
cellulose fibers are degraded by the migrating swarm colony, leaving a hole in the centre 
of the paper (Supplementary Fig. S6c).  
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Sugar utilisation. In medium supplemented with sugar, SBCm007T grew well in the 
presence of starch, fructose, saccharose, molasses and lactose. Poor growth was observed 
upon supplementation with maltose, D-glucose, xylose, sorbitol, D-galactose, arabinose, 
and mannose. In the presence of soluble starch, a clear halo was produced after flooding 
with iodine solution, suggesting hydrolysis.  
 
Nitrogen and peptone sources. Swarming cells were observed in the presence of 
potassium nitrate and aspartic acid. Better growth was exhibited in the latter substrate, 
showing more scattered migrating cells in the agar. However, no evidence of swarming 
could be observed after the incorporation of glutamic acid, urea, and potassium nitrate. 
 
The most pronounced swarming, as reflected by the colony diameter, was seen in 
medium supplemented with Marcor peptone and neopeptone. Poor growth was observed 
in casitone, casamino acids, Bacto peptone, tryptone, and phytone. 
 
Antibiotic resistance. SBCm007T was found to be sensitive to carbenicillin, tetracycline, 
spectinomycin, tobramycin, gentamycin, oxytetracycline, rifamficin, apramycin, 
ampicillin, and streptomycin. Growth was observed in neomycin, kanamycin, and 
hygromycin, indicating its resistance. 
 
Fatty acid and DNA G + C analyses. 
The predominance of straight chain fatty acids (90.10 %) (Table1), and presence of the 
biomarker hydroxy FA C17:1 2OH supports SBCm007Taffiliation to the Sorangiineae 
suborder. The major fatty acids were C16:1ω7c (29.79 %), C18:1ω9c (29.24 %), and C16:0 
(13.28 %). The amount of C16:1ω7c shows similarity with Polyangium, Chondromyces, and 
Jahnella, but differs from the first two genera by the unusual elevated amount of C18:1ω9c. 
In addition, SBCm007T also differs in the total amount of branched-chain fatty acids, 
amounting to almost 10 %. The absence of the polyunsaturated fatty acid C18:2ω6,9c and 
branched-chain hydroxy fatty acid further supports the dissimilarity of SBCm007T to 
Chondromyces and Polyangium. The detection of anteiso C17:0 FA (5.15 %) appears to be 
not only exclusive to marine myxobacteria, but also seems distributed to some terrestrial-
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dwelling isolates (Garcia et al., 2011). The DNA G + C content of the novel isolate is 
65.6 mol %. 
 
     Table 1. Percent cellular fatty acid composition of SBCm007T. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phylogenetic analysis. SBCm007T shows closest 16S rRNA gene sequence identity (95 
%) to a clone of an uncultured bacterium (AF280858), Sorangium cellulosum strains (95 
%), and with other undescribed Sorangiineae isolates (96-97 %, GenBank Accession 
number GU249611-GU249613). Its similarity to type strains of Chondromyces was 
determined between 94.2 % – 95.2 %, whereas there was 96 % – 97.3 % identity with 
Polyangium. In addition, its close identity with the latter genus supports its clustering in 
the phylogenetic tree (Fig. 4). The phylogenetic divergence of SBCm007T to the 
Fatty acid % 
Saturated straight-chain   
     C14:0 0.43 
     C15:0 0.19 
     C16:0 13.28 
     C17:0 1.21 
     C18:0 5.45 
Unsaturated straight-chain  
     C14:1 ω2c 0.74 
     C14:1ω5c 0.72 
     C15:1ω5c 0.08 
     C16:1ω7c 29.79 
     C16:1ω9c 4.72 
     C17:1ω7c 0.74 
     C18:1ω9c 29.24 
Hydroxy straight-chain  
     C17:1 2-OH 1.51 
O-Alkylglycerols (OAG)  
     C15:0 0.07 
     C16:0 1.93 
Branched-chain  
     iso-C15:0 3.61 
     iso-C16:0 0.34 
     anteiso-C17:0 5.15 
Branched-chain OAG  
     iso-C15:0 0.13 
Branched-chain DMA  
     iso-C15:0 0.67 
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Chondromyces cluster was unexpected, as it exhibited typical Chondromyces fruiting 
body formation. SBCm007T represents a novel taxon closely related to Polyangium, and 
is proposed herewith to occupy a novel genus and species. In addition, the topology 
clearly shows the divergence of the novel isolate to the type strain of Sorangium (95.3 %) 
and Byssovorax (95.2 %). Its position in the phylogenetic tree was also supported by a 
previous study (Garcia et al., 2010). 
 
 
Figure 4. Phylogenetic position of Pseudochondromyces catenulatus SBCm007T in 
suborder Sorangiineae, constructed using the maximum likelihood program (PHYML). 
The numbers at branchpoints show the level of bootstrap support based on 1000 
resamplings. Only values greater than 60 are shown. Bar, 0.01 substitution per nucleotide 
position. 
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Description of Pseudochondromyces gen. nov. 
Garcia, Xiao-Ming and Müller 
 
Pseudochondromyces Pseu. do. chon. dro. my’ces. Gr. adj. pseudês false; N.L. masc. n. 
Chondromyces a myxobacterial genus name, Chondromyces; N.L. masc. n. 
Pseudochondromyces the false Chondromyces. 
 
Vegetative cells are long cylindrical rods with rounded ends. Colony moves by gliding 
pseudoplasmodial bands, often penetrating to the agar. Swarm stains negative in Congo-
red. Myxospores resemble vegetative cells but are slightly refractile, smaller, and 
enclosed in sporangioles. Fruiting body is composed of sporangioles. Degrade bacteria, 
yeast, and cellulose. The type species is Pseudochondromyces catenulatus. 
 
Description of Pseudochondromyces catenulatus. sp. nov., nom. rev. (ex Thaxter 
1904). Garcia, Xiao-Ming and Müller 
 
Pseudochondromyces catenulatus ca. te. nu' la. tus. L. dim.n. catenula, a small chain; L. 
masc. suff. -atus, suffix used in adjectives meaning provided with; N.L. masc. adj. 
catenulatus, with small chains (of sporangioles). 
 
Show all the characteristics of the genus. Vegetative cells are long slender fat rods, 1.2–
1.4 x 5.0–15.0 μm, and phase dark. Swarms are pale to deep orange, pseudoplasmodial-
type with band-shape end, burrowing deep into the medium. Fruiting body is composed 
of a stalk and chains (2 – 5, common 3 – 4) of oval to spherical sporangioles connected 
by thin string of slime. Solitary to cluster of sporangioles without stalk are also produced 
in the agar. Myxospores are cylindrical rods (3 – 7 μm x 1.2 – 1.3 μm) with rounded 
ends, partially refractile, and enclosed in sporangiole. Agar is degraded and liquefied. 
Bacteria and yeast are lysed. Cellulose is also degraded. Exhibits resistance to neomycin, 
kanamycin, and hygromycin. Sensitive to carbenicillin, tetracycline, spectinomycin, 
tobramycin, gentamycin, oxytetracycline, rifamficin, apramycin, ampicillin, and 
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streptomycin. Major cellular fatty acid components are straight chain C16:1ω7c, C18:1ω9c, 
and C16:0. It has DNA G + C content of 65.6 mol %. 
 
The type strain is SBCm007T (= DSM 24112T, = NCCB 100348T), isolated from a piece 
of decaying wood collected in China. 
 
ACKNOWLEDGEMENTS 
X. Q.-M. thanks the Chinese Ministry of Science and Technology for the grant [(F) 
2007DFA30970] in this project. We are grateful to Dr. Jean P. Euzéby for etymological 
correction, and to Ms. Janet Lei for proof reading of this manuscript. 
 Chapter II 
48 
 
REFERENCES 
Dawid, W. (2000). Biology and global distribution of myxobacteria in soils. FEMS 
Microbiol Rev 24, 403–427. 
Drummond, A. J., Ashton, B., Buxton, S., Cheung, M., Heled, J., Kearse, M., Moir, 
R., Stones-Havas, S., Sturrock, S., Thierer, T. & Wilson, A. (2010). Geneious Pro 
5.0.2, Available from http://www.geneious.com. 
Felsenstein, J. (1985). Confidence limits on phylogenies: An approach using the 
bootstrap. Evolution 39, 783–791. 
Garcia, R. O., D. Krug, & Müller, R. (2009a). Discovering natural products from 
myxobacteria with emphasis on rare producer strains in combination with improved 
analytical methods. In Methods in enzymology: complex enzymes in microbial natural 
product biosynthesis, vol. 458, part A, pp. 59–91. Edited by D. Hopwood, Burlington: 
Academic Press. 
 
Garcia, R. O., Reichenbach, H., Ring, M. W. & Müller, R. (2009b). Phaselicystis 
flava gen. nov., sp. nov., an arachidonic acid-containing soil myxobacterium, and the 
description of Phaselicystidaceae fam. nov. Int J Syst Evol Microbiol 59, 1524–1530. 
 
Garcia, R., Gerth, K., Stadler, M., Dogma Jr., I. J.& Müller, R. (2010). Expanded 
phylogeny of myxobacteria and evidence for cultivation of the unculturables. Mol 
Phylogenet Evol 57, 878–887.  
 
Garcia, R.; Pistorius, D.; Stadler, M.; & Müller, R. (2011). Fatty acid related 
phylogeny of myxobacteria as an approach to discover polyunsaturated omega 3/6 fatty 
acids. J Bacteriol 193, 1930–1942. 
Guindon S.  & Gascuel O. (2003). A simple, fast, and accurate algorithm to estimate 
large phylogenies by maximum likelihood. Syst Biol 52, 696−704. 
Huelsenbeck, J. P. & Ronquist, F. (2001). MrBayes: Bayesian inference of 
phylogenetic trees. Bioinformatics 17, 754–755. 
Kimura, M. (1980). A simple method for estimating evolutionary rate of base 
substitution through comparative studies of nucleotide sequences. J Mol Evol 16, 111–
120. 
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., 
McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., 
Gibson, T. J. & Higgins, D.G. (2007). Clustal W and clustal X version 2.0. 
Bioinformatics 23, 2947–2948. 
 
 Chapter II 
49 
 
Li, G., Shimelis, O., Zhou, X. & Giese, R. W. (2003). Scaled-down nuclease P1 for 
scaled-up DNA digestion. Bio Techniques 34, 908−909. 
 
McCurdy, H. D. (1969). Studies on taxonomy of the Myxobacterales I. Record of 
Canadian isolates and survey of methods. Can J Microbiol 15, 1453−1461. 
 
McNeil, K. E. & Skerman, V. B. D. (1972). Examination of myxobacteria by scanning 
electron microscopy. Int J Syst Evol Microbiol 22, 243−250. 
Reichenbach, H. (2005). Order VIII. Myxococcales. Tchan, Pochon and Pre´vot 1948, 
398AL. In Bergey’s Manual of Systematic Bacteriology, 2nd edn, vol. 2, part C, pp. 1059–
1072. Edited by D. J. Brenner, N. R. Krieg, J. T. Staley & G. M. Garrity. New York: 
Springer. 
Reichenbach, H. (2006). The Genus Lysobacter. In The Prokaryotes:a Handbook on the 
Biology of Bacteria,3rd, edn, vol. 6, part 3, pp. 939–957. Edited by M. Dworkin, S. 
Falkow, E. Rosenberg, K. H. Schleifer & E. Stackerbrandt. New York: Springer. 
Reichenbach, H., Lang, E., Schumann, P. & Sproer, C. (2006). Byssovorax cruenta 
gen. nov., sp nov., nom. rev., a cellulose-degrading myxobacterium: rediscovery of 
'Myxococcus cruentus' Thaxter 1897. Int J Syst Evol Microbiol 56, 2357−2363. 
Saitou, N. & Nei, M. (1987). The neighbor-joining method: A new method for 
reconstructing phylogenetic trees. Mol Biol Evol 4, 406–425. 
Shimelis, O. & Giese, R. (2006). Nuclease P1 digestion/high-performance liquid 
chromatography, a practical method for DNA quantitation. J Chrom 1117, 132–136. 
 
Shimkets, L. J., Dworkin, M. & Reichenbach, H. (2006). The Myxobacteria. In The 
Prokaryotes: a Handbook on the Biology of Bacteria,3rd edn, vol. 7, pp. 31–115. Edited 
by M. Dworkin, S. Falkow, E. Rosenberg, K. H. Schleifer & E. Stackerbrandt. New 
York: Springer. 
Skerman, V. B. D.; McGowan, V. & Sneath, P. H. A. (1980). Approved lists of 
bacterial names. Int J Syst Bacteriol 30, 225−420. 
Thaxter, R. (1904). Contributions from the cryptogamic laboratory of Harvard 
University LVI. Notes on the Myxobactericeae. Bot Gaz 37, 405–416. 
 
 
 
 
 
 
 Chapter II 
50 
 
 
 
 
Supplementary Figure S1. Dissecting photomicrographs of swarm colonies on agar. (a) Polyangium sorediatum Pl s12T, (b) 
Pseudochondromyces catenulatus SBCm007T Bar, 90 μm. 
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Supplementary Figure S2. Fruiting body of SBCm007T in agar (a) Dissecting photomicrograph of solitary sporangiole. (b) Slide 
mount of sporangiole cluster, phase-contrast. Bar. 15 μm.  
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Supplementary Figure S3. Chain of sporangioles. (a) Dissecting photomicrograph of glassy slime connecting the stalk and chain of 
sporangioles (arrow). (b-c) String connection between sporangioles (arrow). (d) Long chain of sporangioles. (e) end section of 
developing sporangial chain, (f-g) cleavage site between sporangioles.  Photomicrographs taken under dissecting (a-b), phase-contrast 
(c-d), and ESEM (e-f) microscope. Bar, 50 μm (a-b), 20 μm (c), 40 μm (d). 
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Supplementary Figure S4. ESEM photomicrographs of SBCm007T stalk. (a) Rod-shaped cells on the base of the stalk. (b) base of 
the stalk showing their union. (c) stalk close to the sporangiole chain.  
 
 
 
 
 
 Chapter II 
54 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S5. Agar degradation and liquifaction of Pseudochondromyces 
catenulatus SBCm007T on yeast medium (VY/2). Bar, 10 mm.  
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Supplementary Figure S6. Cellulose degradation pattern in myxobacteria. (a) Pseudochondromyces catenulatus SBCm007T. (b) 
Sorangium cellulosum. (c) Byssovorax cruenta. (d-f) Characteristic pattern in P. catenulatus. (d) Cellulose fibre breaks, (e) Filter 
paper degradation with agar retraction. Dotted square shows the original size of the paper.  (f) Clearing of cellulose powder spot on 
agar by the gliding cell clump. Bar, 1.5mm (a), 4.0mm (b), 2.0mm (c), 500μm (d), 4.5mm (e), 300μm (f).
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Aetherobacter fasciculatus sp. nov., Aetherobacter rufus sp. nov., omega-3-
rich polyunsaturated fatty acid-producing myxobacteria, and the 
description of Aetherobacter gen. nov. 
 
Ronald Garcia, Marc Stadler, and Rolf Müller 
 
 
Running Title: Aetherobacter, omega-3-producing myxobacteria 
 
Subject Category: New Taxa – Proteobacteria 
 
 
 
Abstract 
Bacterial strains designated as SBSr002T and SBSr003T were isolated in 2007 from an 
Indonesian soil sample containing pieces of roots and other decaying plant material taken 
from the Landsweiler-Reden collection, Germany. The organisms were recognised for their 
burrowing swarm in the agar and cluster of sporangioles containing short rod myxospores. 
Vegetative cells are Gram-negative rods. The novel isolates exhibit a bacteriolytic-type of 
nutrition. The strains are mesophilic, aerobic to microaerophilic, chemoheterotrophic, and 
show resistance to various antibiotics. Major fatty acids are straight chain iso-C15:0, and C22:6 
(n-3) (docosahexaenoic acid, DHA). The G + C content of their genomic DNA is 68 – 69 mol 
%. The 16S rRNA gene sequence shows closest similarity (96-98%) to clones of uncultured 
bacteria (GenBank accession number: FJ479473, FN421522), Byssovorax cruenta, and 
Sorangium cellulosum strains.  
 
 
 
 
 
Abbreviations  
PUFA: Polyunsaturated fatty acid 
EPA: Eicosapentaenoic acid 
DHA: Docosahexaenoic acid 
AA: Arachidonic acid 
 
The GenBank/EMBL/DDBJ accession numbers for the 16S rRNA gene sequences of the 
novel strains are GU249609 and GU249610. 
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INTRODUCTION 
Myxobacteria have gained recognition in the past for their distinctive biology, developmental 
cycle, and production of novel and interesting secondary metabolites (Weissman & Müller, 
2010; Wenzel & Müller, 2009). Myxobacterial cells glide and, under starvation conditions, 
develop into resting cells which are safely packed in the fruiting body. The production of 
secondary metabolites by myxobacteria appears to be a defense mechanism of the gliding 
cells to protect themselves from other microorganisms in the surrounding environment. In 
this study, we present different elements of exciting application found in novel myxobacteria 
during chemical characterisation. Surprising was the discovery of omega-3 polyunsaturated 
fatty acid (PUFA) in the novel isolates, although this is not the first report of PUFAs in 
myxobacteria (Garcia et al., 2009b). Due to their health benefits for humans, PUFAs are 
commercially and medically important fatty acids (Horrocks & Yeo, 1999). Many issues have 
been raised concerning the current market source (fish oil), thus necessitating the ongoing 
search for a more secure and sustainable alternative source (Ward & Singh, 2005). In this 
study, we highlight the unique characteristic of the novel myxobacterial isolates to produce 
high percentages of omega-3 fatty acids and describe their unusual phenotypic features along 
with phylogenetic and molecular data, leading to the proposal of new taxa. 
 
Methods 
Isolation and Cultivation. Strain SBSr003T was isolated using the filter paper-baiting 
method on mineral salt agar, while SBSr002T was isolated from water agar baited with 
Escherichia coli. (Shimkets et al., 2006). By cutting the colony edge and repeated transfers 
onto new medium (water agar), the strains were isolated. They are routinely cultivated and 
maintained in buffered yeast agar (VY/2) medium (Garcia et al., 2009a). 
 
Microscopy and Morphological Examination. Swarming colonies and fruiting body 
morphology observations were described previously (Garcia et al., 2009b) Vegetative cells 
and myxospores were studied using phase-contrast microscope (Axiostar, Carl Zeiss). All 
growth stages were observed on water agar, MDIG agar (0.3 % Casitone, 0.35 % Glucose, 
0.05 % CaCl2·2H2O, 0.2 % MgSO4·7H2O, pH 7.2 adjusted with KOH), and buffered yeast 
agar. 
 
Microbial predation test. Overnight culture of Escherichia coli, Hansenula anomala, 
Psedumonas stutzeri, Micrococcus luteus were used as bait in water agar medium. Growth of 
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myxobacterium and microbial lysis, as indicated by clearing of the streaked bait, was 
determined after 5-7 days of incubation at 30°C. 
 
Physiological and biochemical tests. Reactions of vegetative cells to Gram stain was 
analysed according to the standard microbiological method, whereas Congo Red staining of 
the swarm colony was done according to McCurdy (1969). Catalase test was performed using 
3.0% H2O2. Cellulose degradation was performed in water and VY/2 agar overlaid with filter 
paper (2.0 x 1.0 cm) and a drop of cellulose powder on the other section of the agar. 
Degradation assay for chitin was also performed in the same media but only with a drop of 
chitin powder (Sigma) solution. Growth determination on xylan and skim milk agar was 
previously described (Garcia et al., 2009b). All incubations were performed at 30°C for 1 to 
2 weeks. 
 
Growth responses to pH, temperature, sugar and nitrogen sources, and antibiotics. 
Growth responses to different levels of temperature, and antibiotic resistance were tested in 
buffered VY/2 agar. For pH tolerance, VY/2 agar was adjusted accordingly. In parallel, the 
latter test and the temperature response tests were also studied in broth MD1G and CG (same 
as MD1G, but without salts) medium, shaken at 160 rpm, 30 °C. Tests for different sugar 
sources were also performed in the same media but glucose was substituted with the sugar 
being tested. Tests for different peptone and inorganic nitrogen sources were also performed 
in MD1G medium, but substituted with the corresponding substrate being tested. All tests 
were incubated for 8 days at 30ºC, except for the temperature response tests, which were also 
incubated at 18ºC, 22ºC (room temperature), 35°C, and 37ºC. 
 
Fatty acid and G + C content analyses. Cell pellet from actively growing culture was 
obtained from MD1G medium shaken at 160 rpm, 30°C. Cellular fatty acid extraction from 
triplicate samples taken from 5-d-old culture was performed using the fatty acid methyl esters 
(FAME) method and analysed by GC−MS (Garcia et al., 2011). The mol percent DNA G + C 
content of the novel bacteria was determined according to standard HPLC methods (Shimelis 
& Giese, 2006; Li et al., 2003).  
 
16S rRNA gene sequencing and phylogenetic analyses. Isolation of genomic DNA for 16S 
rRNA gene amplification was previously described (Garcia et al., 2009b) and prepared from 
actively growing culture taken from MD1G medium. The other 16S rRNA gene sequences 
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used in this study were obtained from GenBank. Alignment of the sequences was performed 
using the rapid multiple sequence alignment based on fast Fourier transform (MAFFT), 
v.6.814b (Katoh et al., 2002), and distance matrices were calculated using the Jukes-Cantor 
model (Jukes & Cantor, 1969). The phylogenetic tree was then constructed using the 
maximum likelihood method (PHYML v2.4.5) (Guindon & Gascuel, 2003), with bootstrap 
calculated for 1000 replicates (Felsenstein, 1985). The phylogenetic tree was also confirmed 
using the neighbour-joining method (Saitou & Nei, 1987). All programs are packed in the 
Geneious Pro 5.0.2 software suite (Drummond et al., 2010).  
 
RESULTS AND DISCUSSION 
 
Morphological and cultural characteristics 
Vegetative cells. The vegetative cells in slide mounts were long and slender phase-dark rods 
measuring 1.1−1.2 x 3.0−7.0 μm (Fig. 1a-1b). Poles of the cell were rounded, representing 
Sorangiineae like morphology. Cells were motile by gliding on the surface as well as under 
the agar. Vegetative cell pellets taken from MD1G medium were whitish to yellowish-
orange. 
 
Swarm. On lean water agar medium, the strains grew as thin and transparent colonies, while 
a yellowish colour could be observed on MD1G medium. In buffered yeast agar, both strains 
produced characteristic deep agar swarming patterns, with high cell density along their 
colony edges (Fig. 1c-1d). Migrating cells move coherently while, at the same time, clearing 
the yeast cells and leaving the centre of the colony clear. Shallow colony depressions were 
found on surface of the medium. The two species can be distinguished through their swarm 
colour. A. rufus SBSr003T exhibits a white to cream-coloured colony, whereas the colonies of 
A. fasciculatus SBSr002T appear yellowish-orange. Another remarkable feature of these 
bacteria in yeast agar is that swarming cells convert into fruiting bodies once they reach the 
edges of the Petri dish. The alternative fate is death of the swarming cells, thus rendering 
them unrecognisable.  
 
Fruiting body. In A. fasciculatus SBSr002T, the fruiting bodies appear as yellowish-orange 
to golden in colour (Fig. 1e), often found under the agar as larger sori (30.0 x 50.0 μm) 
composed of 5-20 tiny sporangioles (10.4 x 11.4 μm). The novel isolates produce much 
smaller sporangioles and sori in comparison to Byssovorax and Sorangium. The ability of the 
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latter to develop fruiting bodies within cellulose fibre strands contributes to the significant 
difference to Aetherobacter. We also have never encountered black sporangioles, as in some 
strains of Sorangium, in our novel bacterial isolates. Their difference to Byssovorax is clearly 
evident in the size and colour of sporangioles, as they are bigger (60–180 µm) and more 
intensely red in colour.  
 
In VY/2 and water agar, SBSr003T fruiting bodies appeared red to vermilion in colour, 
developing as mounds (120 x 140 μm) or as very long rolls (340 x 400 μm  - 1900 x 2900 
μm), visible to the naked eye (Fig. 1f).  The fruiting body was composed of tiny oval to 
spherical sporangioles (6.0 – 12.0 μm), compactly arranged in small sori (14.0 x 15.0 μm - 16 
x 26 μm), and development starts as white humps of cellular aggregation.  
 
Myxospores. Crushed sporangioles released tightly packed and slightly optically refractive 
rod cells, presumably myxospores. These were short and nearly as wide as the vegetative 
cells, with rounded ends, and desiccation-resistant (Fig. 1g-1h). In A. fasciculatus, myxopores 
appear much larger (1.0 – 1.2 μm x 3.2 – 4.0 μm) than in A. rufus (1.0 – 2.0 μm). 
 
Physiological characteristics 
 
Staining and lytic properties. Vegetative cells are Gram-negative and catalase-positive, 
while the swarm colony was unstained with Congo red, suggesting it is not a 
Cystobacterineae. In water agar baited with live E. coli, the swarm spreads thinly and, upon 
contact with bait, wave-like or rolls of swarm are produced. The baited bacterium was 
completely degraded after 2-3 days of incubation, depending on the inoculum diameter. 
Fruiting bodies typically developed after lysis of bait. The novel isolates differ from the 
related genera Sorangium and Byssovorax by their inability to degrade cellulose on Cel−3 
agar and filter paper in ST21 agar. Chitin powder on CT−7 agar was not degraded by the 
advancing swarms. Partial agar degradation was commonly observed in most agar media 
used for cultivation. In soft yeast agar medium (< 1% agar), the novel isolates swarm quickly, 
with migrating cells typically localised under the agar. 
 
Growth responses to temperature and pH. In yeast agar, the fastest spreading colonies and 
largest swarm diameters were seen at 30ºC. Both novel isolates can tolerate growth at 18ºC 
on the same agar but no growth occurred at 37ºC. The two strains differ in their temperature 
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optima. SBSr003T can tolerate shaking cultivation at 22°C, whereas SBSr002T cannot. 
Although both strains exhibit optimal growth at 28°C – 30°C, A. rufus tolerates a wider 
temperature range (22 °C – 30 °C ) than A. fasciculatus.  
 
Both strains can also grow in yeast agar in a pH of range 5 – 8, with the largest swarm 
diameter observed at pH 7.0. The same observations were also determined in broth media, 
but clearly more evident through optimal growth at pH 6.5 – 7.2, as indicated by dense 
biomass. No evidence of growth for both strains was found below a pH of 4.0 or above a pH 
of 9.0. 
 
Sugar Source. The two strains also differ in their sugar requirements. Strain SBSr003T 
tolerated all sugars tested (glucose, fructose, galactose, lactose, saccharose, starch, raffinose, 
mannose, and maltose), displaying almost the same amount growth; in contrast, SBSr002T 
cannot tolerate starch and grows poorly in mannose. This is in agreement with the 
supplementation experiment performed in agar, as measured by the swarm diameter.   
 
Peptone and Inorganic Nitrogen Sources. In SBSr003T, casitone produced better growth 
than peptone, neopeptone, or tryptone. Poor growth was observed in phytone, while no 
evidence of growth was observed in casamino acids when they were supplemented. 
SBSr002T shows almost the same growth reaction to different peptone sources. Casitone, 
peptone, neopeptone all yield high cell densities, whereas moderate yields were seen with 
tryptone, and poor yields were observed in phytone and casamino acids. 
 
Inorganic nitrogen sources, including glutamic acid, aspartic acid, ammonium sulfate, and 
potassium nitrate, result in good growth of SBSr003T, while poor growth was observed in 
urea. In SBSr002T, good growth was exhibited on glutamic acid, aspartic acid, and potassium 
nitrate. The strain hardly grows in urea and ammonium sulfate. 
 
Antibiotic resistance. SBSr003T was resistant to gentamycin, ampicillin, and neomycin, 
whereas sensitivity was observed in apramycin, tobramycin, kanamycin, spectinomycin, 
hygromycin B, tetracycline, oxytetracycline, streptomycin, carbenicillin, and rifampicin. 
Antibiotic resistance of SBSr002T was seen in gentamycin, apramycin, tobramycin, 
streptomycin, ampicillin, neomycin and hygromycin B, whereas sensitivity was observed in 
kanamycin, spectinomycin, tetracycline, oxytetracycline, carbenicillin, and rifampicin. 
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Figure 1. Growth stages of Aetherobacter fasciculatus SBSr002T (top) and Aetherobacter rufus SBSr003T (bottom). Phase dark  vegetative 
cells.  Bar, 10 μm (a-b). Dissecting photomicrographs of swarming colony on buffered yeast agar. Bar, 15mm (c-d).  Dissecting 
photomicrographs of fruiting bodies.  Bar, 300 μm (e-f).  Phase contrast photomicrograps of myxospores. Bar, 10 μm (g, h). 
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Fatty acid profile and mol % G + C content 
Major fatty acids for both strains were iso-C15:0, and C22:6 (n-3) (docosahexanoic acid, 
DHA) (Table 1). The presence of C17:1 2OH indicates that the isolates belong to 
Sorangiineae, a proposed hallmark for this suborder (Garcia et al., 2011). Their position 
in that suborder was further supported by the predominance of straight-chained fatty 
acids. The uniqueness of the isolates was reflected in the presence of DHA; to date, they 
are the only group of myxobacteria capable of producing this type of fatty acid. 
Surprisingly, other PUFAs, such as eicosapentaenoic acid (EPA) and arachidonic acid, 
were also detected.  In order to allow comparative analysis among members of the order, 
the differences in the FA profile among myxobacteria has recently been extensively 
studied (Garcia et al., 2011).The DNA G + C content of the novel bacteria is between 
68.0 – 69 mol %. 
 
16S rRNA gene sequence and phylogenetic analysis  
Complete 16S rRNA gene sequences of the isolates revealed their closest similarity (95% 
– 98%) to uncultured bacteria [GenBank accession: EU881332 (95%), FJ479473 (96%), 
FN421522 (98%)], while their similarity to the culturable bacteria was determined to be 
between 95% - 96% among the cellulose degrading species [Byssovorax cruenta DSM 
14553T (AJ833647), Sorangium cellulosum strains So9857, So ce56]. We note that a 96% 
similarity in the 16S rRNA gene was previously used as justification for the erection of a 
new genus, Enhygromyxa (Iizuka et al., 2003), and thus also consider here the creation of 
the new genus Aetherobacter. This proposal is further supported by the phylogenetic 
clustering of the novel isolates to clones of uncultured bacteria in the neighbour-joining 
tree obtained via BLASTn. 
 
The clustering of SBSr002T and SBSr003T in the phylogenetic tree suggests that they 
belong together in a common taxon, whereas their phylogenetic divergence to Byssovorax 
and Sorangium implies that they belong to a novel genus (Fig. 2). Aetherobacter has been 
previously considered as belonging to a novel genus in a comprehensive myxobacterial 
phylogenetic study (Garcia et al., 2010). 
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Table 1. Fatty acid characteristic of Aetherobacter.  
Fatty acids  SBSr002T SBSr003T
Straight-chain % % 
C13:0 0.04 0.2 
C14:0 0.21 1.23 
C15:0 5.23 8.88 
C15:1 0.2 0.19 
C16:0 3.93 8.65 
C16:0 9,10 CH2 0.42 0.13 
C16:1ω5c 2.94 5.19 
C17:0 3.95 3.64 
C18:0 0.61 7.04 
C20:4ω6 ARA 0.64 - 
C20:5ω3 EPA 6.99 3.95 
C22:6ω3 DHA 18.9 14.96 
C16:0 2-OH 0.75 0.36 
C17:0 2-OH 5.29 2.61 
C17:1 2-OH 0.55 4.26 
O-Alkylglycerols (OAG)   
OAG 3.67 2.47 
OAG 0.46 - 
OAG 0.99 - 
OAG 1.68 - 
OAG 1.11 - 
Branched-chain   
iso-C13:0 0.07 0.08 
iso-C14:0 0.49 0.13 
iso-C15:0 16.44 23.9 
iso-C16:0 5.93 1.76 
iso-C17:0 6.8 3.12 
iso-C17:1ω5c 0.19 - 
iso-C18:0 0.08 - 
anteiso-C15:0 0.01 - 
iso-C17:0 2-OH 0.56 0.07 
anteiso-C15:0 - 0.3 
anteiso-C17:0 8.32 - 
iso-C15:0 OAG - 1.64 
 
* Major fatty acids (> 10 %) are marked in boldface. 
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Figure 2. Phylogenetic position of Aetherobacter showing the clustering to clones of 
unculturable bacteria. The tree was constructed based on 16S rRNA gene sequences using 
the maximum likelihood method (PHYML). The numbers at branch points indicate the 
percentage bootstrap support based on 1000 resamplings. Values greater than 60 % are 
shown. Bar, 0.05 substitution per nucleotide position.  
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Description of Aetherobacter gen. nov.  
Garcia and Müller 
Aetherobacter [Ae.the.ro.bac’ter. Gr. masc. n. Aether Greek God of Light (refers to clear 
and transparent swarming); Gr. fem. n. bacter from Gr. neut.. n. bakterium small rod, 
stick; M.L. masc. n. Aetherobacter clear swarming rod]. 
 
Vegetative cells are moderately long and slender cylindrical rods with blunt ends; 
movement occurs by gliding on surface and under the agar. Swarm is film-like to 
transparent-clear, with ring-like colony shaped in yeast agar. Congo-red-negative, colony 
edges characterised by coherent migrating cells penetrating deep into the medium; agar 
slightly depressed. Myxospores are refractive slender rods with blunted ends, shorter than 
vegetative cells, enclosed in sporangial wall. Fruiting bodies appear as tiny ovoid 
sporangioles, usually compact or clustered. Yeasts and bacteria are strongly degraded. 
Contain high amount of iso-C15:0 and omega-3 polyunsaturated fatty acid. Percent G + C, 
68.0 – 70 mol %. The type species is Aetherobacter rufus. 
 
Description of Aetherobacter fasciculatus sp. nov.  
Garcia and Müller 
Aetherobacter fasciculatus [fasc.i.cu'la. L. masc. n. fasciculum little bundles or packets 
(refers to the arrangement of sporangioles)].  
 
Exhibits all characteristics of the genus. Vegetative cells are fat rods, 1.2−1.3 x 2.9−5.7 
μm in size and phase dark. Swarms are yellowish-orange, showing complete clearing of 
yeast cells, with shallow depressions on the surface of agar, often deeply penetrating the 
medium. Fruiting bodies are yellow-orange in colour, often under the agar, with sori (30 
x 50 μm) composed of 5-20 tiny sporangioles (10.4 x 11.4 μm), tightly arranged as 
bunches. Myxospores are refractive, stout rods, with rounded ends similar but shorter 
(1.0−1.2 x 3.2−4.0 μm) than vegetative cells, enclosed in a sporangial wall. Nutritional 
type is bacteriolytic, yeast degrader. Cellulose and chitin not degraded. Good growth in 
saccharose, fructose, D- mannose, and L-arabinose. Resistant to a broad spectrum of 
antibiotics: gentamycin, apramycin, tobramycin, streptomycin, ampicillin, neomycin, and 
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hygromycin B. Sensitive to kanamycin, spectinomycin, tetracycline, oxytetracycline, 
carbenicillin, and rifampicin. Major cellular fatty acid components are iso-C15:0 and 
DHA. Produce EPA. Mol percent G + C is 68.9.  
 
The type strain is SBSr002T (= DSM 24601T = NCCB 100377T), isolated in November 
2007 from an Indonesian soil sample taken from the Landsweiler-Reden collection, 
Germany.  
 
Description of Aetherobacter rufus sp. nov. Garcia and Müller 
Aetherobacter rufus (ru.fus. L. masc. adj. rufus red).  
 
Exhibits all characteristics of the genus. Vegetative cells are fat rods, 1.0−1.2 x 3.0−6.0 
μm in size, and phase-dark. In yeast agar, the swarm moves coherently in a ring or 
circular shape, with white cells concentrated at the edges of the ring and the middle of the 
swarm appearing clear and transparent. Exhibits shallow agar depressions. Fruiting 
bodies are red to vermilion in colour, appearing as a mound (120 x 140 μm) or long rolls 
(340 x 400 μm – 1900 x 2900 μm). Composed of tiny sporangioles (6-12 μm) compacted 
in a sorus (14 x 15 μm – 16 x 26 μm). Myxospores are slightly refractive, stout and short 
rods (1·0−2·0 μm) with rounded ends, enclosed in a sporangial wall. Lyse bacteria and 
yeast cells. Cellulose and chitin not degraded. Shows good growth in the presence of 
sugars: arabinose, fructose, galactose, glucose, mannose, molasses, sorbitol, xylose, 
cellobiose, lactose, maltose, saccharose, and soluble starch. Resistant to ampicillin, 
neomycin, and gentamycin. Sensitive to apramycin, tobramycin, kanamycin, 
spectinomycin, hygromycin B ampicillin, tetracycline, oxytetracycline, streptomycin, 
carbenicillin, and rifampicin. Major cellular fatty acid components are iso−C15:0 and 
DHA. Also produce EPA. Mol percent G + C is 68.0. 
 
The type strain is SBSr003T (= DSM 24628T = NCCB 100378T), isolated in December 
2007 from an Indonesian soil sample, taken from the Landsweiler-Reden collection, 
Germany.  
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Chapter III. Discussion 
 
 
A. General Scope of this Study 
This work aims mainly on the discovery of natural products from myxobacteria. In order 
to find novel bioactive compounds, the study focused on strain discovery by combining 
microbiological, chemical, molecular, and phylogenetic techniques. Several new strains 
representing new genera and a new family were isolated and characterised. Their 16S 
rRNA genes were analysed and compared to representative strains to determine their 
position in the expanded phylogenetic tree. In addition, the significance of fatty acid 
correlation with each strain was illustrated for the first time. Furthermore, the study also 
describes the surprising discovery of diverse polyunsaturated fatty acids in myxobacteria. 
Lastly, the work highlights the isolation of bioactive compounds from the novel genus 
Aetherobacter which could be potential candidates for novel potent anti-cancer therapy. 
 
B. Introduction to myxobacteria and guide to novel strain and compound discovery 
 
1. Discovering Natural Products from Myxobacteria with an Emphasis on Rare 
Producer Strains in Combination with Improved Analytical Methods 
Myxobacteria produce structurally diverse natural products with unique modes of action. 
This study discusses an approach encompassing the discovery of novel myxobacterial 
strains, bioactivity screening, and mining for novel compounds that are possible 
candidates for drug development. Samples have shown that environments exhibiting 
significant biological complexity yield the highest probability of isolating novel taxa. 
This was in concurrence with a previous study on samples representing all geographical 
locations (Dawid, 2000). The interaction and competition by organisms for common 
resources in an environment seem to be important factors for the development of 
bioactive secondary metabolites. As exemplified by compounds acting on the 
cytoskeleton and nucleic acid polymerases, these metabolites are hypothesised to be 
produced by myxobacteria to inhibit eukaryotic competitors in the environment 
(Reichenbach, 2009). 
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Strain recognition, a non-selective approach, efficient and detailed purification 
techniques, and genetic characterisation have led to the systematic identification of novel 
taxa. The discovery of novel strains with unknown metabolites revealed that the potential 
of myxobacterial diversity and natural products are far from exhausted. Sophisticated 
high resolution mass spectrometry and guided bioassays play key roles in natural product 
discovery, as will be discussed towards the end of this chapter.  
 
Sorangiineae hold great promise for novel myxobacterial discovery, as members of this 
suborder are difficult to culture and purify; it is likely that many members have been 
missed by earlier investigators. The isolation methods employed here were designed to 
mimic the natural predatory environment of myxobacteria, simulating a natural 
environment during cultivation, with the knowledge that all myxobacteria are highly 
specialised in biomacromolecule degradation (Reichenbach, 1999b). Using these 
methods, a large number of novel strains belonging to a novel family and to proposed 
novel genera were isolated. Some of these bacteria were previously described ones but 
never cultivated (Thaxter, 1904) and thus considered to be rare (Reichenbach, 2005). The 
rediscovery of Chondromyces catenulatus illustrates this method and this strain is 
proposed here as a novel genus and species (Pseudochondromyces catenulatus). This 
group, which includes the Phaselicystis (Garcia et al., 2009b), Aetherobacter, and 
Minicystis appear to represent the ‘‘uncultured’’ taxa of myxobacteria. The unusual 
characteristics of these isolates will be discussed in their respective sections. 
Fundamentals of the success of this method in unearthing novel taxa were elaborated, 
including methods of preservation. Data suggest that tropical and subtropical samples 
represent the best source of novel myxobacteria capable of producing biologically active 
metabolites. Previous study supports the diversity of myxobacteria in those communities 
(Dawid, 2000). 
 
Using LC-coupled high resolution mass spectrometry, myxobacterial natural products 
were identified. Novel bioactive compounds are uncovered after bioassay-guided 
fractionation against sensitive microorganisms or eukaryotic cell lines. Lymphoma 
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(U937) and cervical carcinoma (KB3.1) cell lines are used as preferred test cell lines due 
to their sensitivity and reproducibility in this study.  
 
Statistical tools represent another approach to mine novel secondary metabolites. In 
Principal Component Analysis (PCA), significant differences between numbers of 
multivariate LC-MS data sets are extracted, thereby creating groups of observations, 
trends, and outliers. Novel compounds are then identified based on significant differences 
in a given set of samples. In combination with a compound-finding algorithm, a 
chromatographic elution profile of the compounds can be differentiated from background 
noise (Krug et al., 2008). This technique is elaborated upon in the following section of 
this manuscript. 
 
2. Efficient Mining of Myxobacterial Metabolite Profiles Enabled by Liquid 
Chromatography–Electrospray Ionisation-Time-of-Flight Mass Spectrometry 
and Compound-Based Principal Component Analysis 
 
Modern spectrometry is an important and reliable tool in the identification and 
characterisation of diverse microbial metabolites. This study specifically focuses on 
diverse Myxococcus isolates and a control strain M. xanthus DK1622. Using accurate 
mass data from high-resolution ESI-TOF measurements, target screening has facilitated 
the rapid identification of known myxobacterial metabolites. At least one of the five 
compound families (myxalamide, myxocheline, DK xanthene, myxochromide, and 
cittilin) was identified in new Myxococcus isolates, suggesting the robustness of the target 
analysis in finding known compounds.  
 
Statistical tools using principal component analysis (PCA) implement an advanced 
compound-based bucketing approach to reveal the presence of other compounds which 
contribute to variation among the metabolite profiles being investigated. Molecular 
formulae generation for potential novel compounds uses exact mass position and isotopic 
patterns, emphasising their significant role in de-replication and compound 
characterisations.  
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Although the tools presented here contribute significantly to the identification of novel 
compounds, they do not reveal anything regarding bioactivity. Conventional approaches 
to novel metabolite discovery, coupled to bioassays, point more directly to a targeted 
compound of interest. The last section of this chapter tackles the discovery of new 
bioactive compounds using the classical approach. 
 
C. Isolation of Novel and Rare Myxobacteria 
 
1. Phaselicystis flava gen. nov., sp. nov., an Arachidonic Acid-Containing Soil 
Myxobacterium, and the Description of Phaselicystidaceae fam. nov. 
 
Unusual myxobacteria were discovered to represent a novel family. The strains (NOSO-
1, SBKo001T) were obtained from a soil sample of decaying plant material, and isolated 
at different times (1988, 2006), places (Namibia, Philippines), and continents (Africa, 
Asia). Although they show cigar-shaped rods with blunted ends, extraordinarily, they 
exhibit white radial vein swarming atypical for the Sorangiineae. So far, this combined 
characteristic has never been described before in this suborder. The thick-walled yellow 
sporangioles distinguish P. flava from members of related Polyangiaceae family. 
 
The uniqueness of the isolates was also reflected in their fatty acid (FA) composition. In 
myxobacteria, the occurrence of C20:4 FA was first documented in ‘halophilic isolates’ 
(Iizuka et al., 2003a, 2003b), although this also appears to be produced by non-related 
marine gliding bacteria (Hosoya et al., 2006; Hosoya et al., 2007). The abundance (12 – 
36%) of C20:4ω6 (arachidonic FA) was first time identified here in strains SBKo001T and 
NOSO-1, while the abundance of C17:1 2-OH and straight-chain FA confirms that both 
strains belong to the Sorangiineae suborder (Garcia et al., 2011). 
 
Although the novel isolates were unable to degrade filter paper, 16S rRNA gene sequence 
analysis revealed their closest similarity (94%) to be with cellulose degrading Sorangium 
and Byssovorax. A bifurcation from Polyangiaceae in the phylogenetic tree suggests that 
the novel clade represent a novel family (Phaselicystidaceae), genus (Phaselicystis) and 
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species (Phaselicystis flava), and its position was confirmed in the expanded 
phylogenetic tree of myxobacteria (Garcia et al., 2010). Phaselicystidaceae was the 6th 
family discovered in myxobacteria, and is so far composed of only one genus. 
 
2. Minicystis rosea, gen. nov., sp. nov., a Pink Myxobacterium  
 
A novel myxobacterial strain, SBNa008T, was isolated in 2007 from Philippine soil 
sample taken in Landsweiler-Reden collection, Germany. The bacterium was noted for its 
loose swarming pattern and undefined colony edges, a characteristic unusual for cigar-
shaped myxobacteria; Sorangiineae normally produced ridge ends with coherent 
swarming. SBNa008T produced an exceptionally thin and almost transparent colony, 
although in higher cell density resulted in pinkish swarming. Unlike most myxobacteria, 
no rippling and veins could be found in the colony. Fruiting bodies show similarity with 
Nannocystis; however the novel myxobacterium produced fruiting bodies much smaller 
in size and often as clusters on agar. Absence of deep agar corrosions and holes in the 
novel isolate additionally emphasise its difference to Nannocystis. Morphological 
features indicate that SBNa008T is a Sorangiineae-type bacterium. 
 
The presence of iso-C15:0, C17:1 2-OH and C20:4 ω6 (arachidonic acid) as major FA cell 
constituents indicates its clustering within the Sorangiineae suborder. Polyunsaturated 
C20:5ω3 (ω-3 eicosapentaenoic acid: EPA) and trace amount of C18:3ω6 (ω-6 γ linolenic 
acid) were also found. The ability of the novel bacterium to produce an ergostane steroid 
(Gawas et al., 2011) seems to be a unique characteristic for this taxon. To our knowledge, 
only a few genera of myxobacteria were described as producing steroids (Bode et al., 
2003; Shimkets et al., 2006); this ability does not seem to be common in the bacterial 
kingdom. 
 
BLASTn analysis of 16S rRNA gene sequences revealed 95 - 96% similarity to clones of 
uncultured bacteria (e.g. EU662572, EU104167, AM490752), whereas 94 - 95% 
similarity was found to members of Sorangiineae [(95% to Byssovorax cruenta 
(AJ833647), 94% to Phaselicystis flava (EU545827), Chondromyces lanuginosus 
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(FJ176774), and Sorangium cellulosum (AM746676)]. The clustering of the novel isolate 
to uncultured bacteria and its novel branch in the phylogenetic tree suggests that 
SBNa008T represents a novel genus (Minicystis) and species (rosea). 
 
3. Pseudochondromyces catenulatus gen. nov., sp. nov., nom. rev., A Rediscovery of 
‘Chondromyces catenulatus’ Thaxter 1904  
 
The surprising discovery of strain SBCm007T unwinds the mystery of Thaxter’s 
uncultured Chondromyces catenulatus. This novel myxobacterium was isolated in 2008 
from a piece of wood collected along a riverbank in China. Isolation began with the 
appearance of Chondromyces-like fruiting bodies, which is composed of a stalk and 
elegant sporangioles. To date, six Chondromyces species are known (Reichenbach, 
2005), although only five were cultivated axenically. C. catenulatus represents the 
uncultured species of Chondromyces, wherein its description relies mainly on its 
appearance in crude culture (Thaxter, 1904). Its second occurrence was documented from 
environmental sample by scanning electron microscopy (SEM) in Australia (McNeil & 
Skerman, 1972). Although the bacterium was never been cultivated, it was still included 
in the approved lists of bacterial names (Skerman et al., 1980). The bacterium was not 
once encountered in their decades-long myxobacteria isolation-screening and thus 
reported to be rare (Reichenbach, 2005).  
 
This study describes the isolation and characterisation of SBCm007T, a strain initially 
identified as Chondromyces catenulatus, which, for more than a century (107 years), had 
never been brought into axenic culture. Further characterisation of the isolate based on 
morphology, chemo-physiology, genetics, and phylogenetics provides convincing 
evidence that the bacterium belongs to a novel genus. 
 
SBCm007T exhibits dual fruiting stages, one as a typical Chondromyces on surface of the 
agar – composed of a stalk and sporangioles, and second as Polyangium-like sporangioles 
in the agar. This bi-phasic feature has never been described before in myxobacteria. 
Pseudoplasmodium, which has only previously been observed in Byssovorax 
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(Reichenbach et al., 2006), was also seen in the novel isolate but differs in its orange 
band-shaped swarm edges penetrating deeply into the agar. It also differs from 
Byssovorax in its absence of wrinkled parchment-like slime trails on filter paper. The 
novel bacterium was distinguished from Chondromyces by its agar liquefaction and 
cellulose degradation ability. The latter characteristic was supported by high protein 
similarity (59 %) to CelA and CelB in Sorangium cellulosum after BLASTp search of a 
translated nucleotide sequence in contig 00219 of the SBCm007 genome. 
 
The difference of SBCm007T to Chondromyces was also mirrored in C16:0 and C18:1ω9c as 
major FAs. The former was absent in Chondromyces, while the latter was generally found 
in low levels except for one species (C. robustus). Phylogenetic analysis revealed 
SBCm007T divergence to Chondromyces, surprisingly finding it to be clustered with 
Polyangium, supporting a previous study (Garcia et al., 2010). Taken together, these data 
suggest that SBCm007T belongs to a new taxon which represents a novel genus and 
species (Pseudochondromyces catenulatus). 
 
4. Aetherobacter fasciculatus sp. nov., Aetherobacter rufus sp. nov., Omega-3-Rich 
Polyunsaturated Fatty Acid-Producing Myxobacteria, and the Description of 
Aetherobacter, gen. nov. 
 
The myxobacterial strains designated as SBSr002T and SBSr003T were isolated from 
dried soil samples taken from Landsweiler-Reden collection, Germany, collected in 
Indonesia. The organisms share common remarkable characteristics for producing 
transparent colonies with swarm edges burrowing deep into the agar (Fig. 3a). This 
feature had not been observed before in myxobacteria and seems to be an indicative of 
microaerophilic or facultative anaerobic behaviour. This is not surprising, given that 
several related taxa have been noted to be capable of anaerobic growth (Coates et al., 
2002; Sanford et al., 2002). As with many other myxobacteria, the novel isolates exhibit 
a bacteriolytic-type of nutrition and mesophilic growth. Although these two novel species 
share many similarities, they differ physiologically and morphologically in some stages 
of development. A. fasciculatus SBSr002T produces bundles of sporangioles (Fig. 3b), 
 Chapter III 
80 
 
whereas SBSr003T exhibit more compact and denser fruiting bodies. They also have 
varying degrees of resistance to antibiotics. In addition, this group is also unusual for its 
fatty acid constituents. Although major FA iso-C15:0 and C17:1 2OH appear typical for this 
family, C20:5ω3 (eicosapentaenoic acid, EPA) and C22:6ω3 (docosahexaenoic acid) are 
unique to this genus. In hundreds of myxobacterial strains screened, including most 
representative type strains, the production of EPA appears exclusive to some genera, 
whereas DHA appears specific for Aetherobacter. Lately, C20:4ω6 identified as arachidonic 
acid (omega-6 FA), was also found in trace amounts (Garcia et al., 2011). These PUFAs, 
particularly the n-3 family, appear to be rare in prokaryotes and are usually produced only 
by a few groups of marine bacteria (Fang et al., 2004; Nichols et al., 1999; Nichols & 
McMeekin, 2002).  
 
The BLASTn similarity (95-99%) of the strains in 16S rRNA gene sequence was found 
closest to clones of uncultured bacteria (e.g. FJ479473, FN421522), suggesting that they 
represent the uncultured group of myxobacteria. Phylogenetic analysis revealed the 
novelty of the isolates, forming a unique cluster in Polyangiaceae, with Byssovorax 
cruenta and Sorangium cellulosum as their sister taxa.  
 
Figure 3. Aetherobacter fasciculatus SBSr002T flourescent lasser scanning 
photomicrograph of fruiting body showing the characteristic bundle-shaped appearance 
of the sporangioles and deep agar growth (white box). 
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D. Phylogeny and Fatty Acids of Myxobacteria 
 
1. Expanded Phylogenetic Tree of Myxobacteria and Evidence for Cultivation of the 
“Unculturables” 
 
The increasing number of isolates discovered in the past decade has led this study to 
construct a new phylogenetic tree of myxobacteria based on 16S rRNA gene sequence. 
To date, 3 suborders, 6 families, 20 genera and 46 species are recognised culturable in 
Myxococcales, as shown by the phylogenetic positions, and distinctions among suborders 
were clearly delineated. This work also covers all species previously studied (Shimkets & 
Woese, 1992; Kaiser 1993; Pradella et al., 2002; Spröer et al., 1999; Ludwig et al., 
1983). The phylogenetic positions of the anaerobes (Anaeromyxobacter, myxobacterium 
strain KC), novel Cystobacterineae (Pyxidicoccus and Cystobacter spp.), the marine taxa 
Plesiocystis (Iizuka et al., 2003a), Haliangium (Fudou et al., 2002), and Enhygromyxa 
(Iizuka et al., 2003b) were clearly demarcated into clusters. Other undescribed isolates 
(‘Paraliomyxa miuraensis’, brackish-water strain SYR-2), which may represent the 
‘slightly halophilic’ taxa, were also included. Changes in the nomenclature of several 
isolates (Polyangium vitellinum Pl vt1T, Polyangium thaxteri Pl t3, Polyangium 
cellulosum, NOSO-1, NOCB-2, NOCB-4) were also emphasised. Overall, the 
phylogenetic placements of these isolates and many other strains were re-affirmed. 
 
The discovery of 9 novel isolates highlights the suborder Sorangiineae, in which they 
may represent new genera or even higher taxa. They appear to represent the so-called 
viable but not culturable (VBNC) group of myxobacteria, as suggested by their high 16S 
rRNA sequence similarity. This supports previous findings in metagenomic studies 
derived from the natural environment and show phylogenetic relatedness to myxobacteria 
(Wu et al., 2005; Jiang et al., 2007; Jiang et al., 2010). ‘VBNC’ may perhaps be a mere 
reflection of the yet unknown physiological and nutritional growth requirements of the 
organism. The nine novel isolates significantly contribute to a clearer distinction between 
the Sorangiineae and Nannocystineae suborders. 
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Myxobacteria are phylogenetically coherent group. Based on at least 4% phylogenetic 
distance, new clades were formed and, on the basis of bracket distance, myxobacteria 
could be divided into 16 clusters supported by tree topology. It is hoped that the proposed 
phylogenetic tree will serve as a key guide to the genetic- and morphology-based 
taxonomy of myxobacteria and also as an important tool for the discovery of interesting 
novel compounds from unexplored novel strains. In addition to the unexplored 
environmental sources, high expectations that novel groups of myxobacteria could 
possibly be isolated by changing the isolation and baiting methods. Novel screening of 
known strains by co-cultivation with other soil bacteria and by simulation of cultivations 
to that of the natural environment are seem to be new stratigies that could lead to 
discovery of potential bioactive compounds.  
 
2. Fatty Acid-Related Phylogeny of Myxobacteria as an Approach to Discover 
Polyunsaturated omega-3/6 Fatty Acids 
 
A comprehensive report of the cellular fatty acid (FA) content in the order Myxococcales 
is presented here for the first time. Unlike other microorganisms, myxobacteria synthesise 
diverse and more complex FAs. These are represented by a vast number of different FA 
types (Fautz et al., 1979; Fautz et al., 1981; Schröder & Reichenbach, 1970; 
Stackerbrandt et al., 2007; Ware & Dworkin, 1973). As much as 58 different FAs have 
been detected in myxobacteria. Sorangiineae appears to be the most sophisticated among 
the three suborders, with the discovery of 49 FAs. In addition, Sorangiineae also appears 
unrepresented in most myxobacterial FA studies. This is perhaps attributed to 
accessibility of the strain, maintained only by a few laboratories, and also appears 
associated to difficulties in handling due to their unknown nutritional metabolism. 
 
The distribution of straight-chain fatty acids (SCFAs) and branched-chain fatty acids 
(BCFAs) supports the clustering of strains in the phylogenetic tree based on 16S rRNA 
gene sequence. Sorangiineae contains higher amounts of SCFA than BCFA, whereas 
Cystobacterineae displays the opposite. In Nannocystineae, the ratio of BCFA and SCFA 
seems dependent on the taxonomic clade. Myxobacteria could also be classified using 
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their predominant FAs and biomarkers. Nannocystineae is remarkably unique among the 
suborders for its absence of hydroxy FAs.  In myxobacteria, only the 2-OH and 3-OH 
FAs were found. Cystobacterineae seems more creative in synthesising diverse FAs of 
the 3-OH type compared to Sorangiineae. The latter suborder is distinguished by absence 
of straight-chained hydroxy FA and, so far, only the iso-C17:0 3-OH has been found. 
However, Sorangiineae are also unique for the presence of C17:1 2OH FA, which appears to 
be a marker for this suborder. 
 
The study also highlights the FA profile of Sorangiineae and the discovery of 8 PUFAs, 
all reportedly new in myxobacteria. Many studies have shown and supported the 
importance and health benefits of PUFAs to humans (Funk et al., 2001; Horrocks & Yeo, 
1999). The PUFAs were identified as linoleic acid, γ-linolenic acid, homo-γ-linolenic 
acid, eicosadienoic acid (all ω6), α-linolenic, eicosapentaenoic acid, docosapentaenoic 
acid, and docosahexaenoic acid (all ω3). Commercially-valuable EPA appears restricted 
to certain genera in Sorangiineae and Nannocystineae, whereas DHA appears exclusive 
to “Aetherobacter.” All isolates within this genus were discovered to be producing 
significant amounts of DHA, EPA and other PUFAs (Stadler et al., 2010). The demand 
for the omega-3 PUFAs in pharmaceutical and food industry is increasing due to their 
health-related benefits (Horrocks & Keo, 1999), and therefore there is a continuous 
search for alternative sources (Fang et al., 2004; Jøstensen & Landfald, 1997; Nichols et 
al., 1999; Singh et al., 1996; Ward & Singh, 2005; Warude et al., 2006; Yano et al., 
1997). 
 
Based on the chemo-phylogeny tree of myxobacteria, the production of omega-3/6 
PUFAs appear to be associated to certain taxa or clades. This correlation seems to be 
more specific to omega-3 FAs, as exemplified by docosahexaenoic acid and 
eicosapentaenoic acid. DHA appears to only be produced by the novel Aetherobacter 
cluster. Using this innovative approach, commercially important omega-3 FAs can be 
predicted in novel myxobacterial isolates. The clustering of three additional strains 
(SBSr001-SBSr003) to Aetherobacter sp. SBSr008 supports the validity of this approach, 
all of which produced significant amounts of EPA and DHA. 
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Although myxobacteria are morphologically related through their gliding ability with 
Herpetosiphon and Flexibacter, FA profile revealed huge differences, agreeing with 
previous studies (Intriago & Floodgate, 1991; Johns & Perry, 1977). In addition, these 
gliding bacteria do not produced PUFAs, except for linoleic acid in Herpetosiphon.  
 
The study concludes that myxobacterial FAs complement findings from 16S rRNA gene 
phylogeny, and is therefore considered to be a valuable tool for the chemo-taxonomic 
classification of myxobacteria, especially for the discovery of new omega-3 FAs 
producer strains.  
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Chapter IV. Production, Isolation, and Biological  
Activity of Novel Secondary Metabolites 
 
 
New biologically active compounds from Aetherobacter (Myxobacteria): Production, 
isolation, and biological activity 
 
Abstract 
In the course of screening for new myxobacterial producer strains, a novel isolate 
proposed to novel genus and species (Aetherobacter rufus strain SBSr003) was isolated. 
Two novel compounds with a molecular weight of 718.3829 were isolated. High-
resolution LTQ-Orbitrap analysis revealed similarities in their chemical formulae, 
C41H54N2O9. Both compounds show selective antifungal activity and, more interestingly, 
exhibit strong cytotoxicity to the human colon tumor cell line HCT-116. Compound A 
shows an IC50 of 81.3 ng/ml, whereas compound B exhibits a slightly lower IC50 value 
(84.8 ng/mL). 
 
Introduction 
Myxobacteria have gained recognition as proficient sources of novel natural products 
with a wide range of biological activities (Weissman & Müller, 2010; Wenzel & Müller, 
2009). Many of the compounds known from this group are derived from Myxococcus and 
Sorangium, and the number of compounds discovered from these two genera appears to 
reflect the number of isolated strains. To date, the latter genus produces the highest 
number of known compounds amongst myxobacteria. Secondary metabolites produced 
by the suborder Sorangiineae account for nearly 64% (48.4% from Sorangium, 10.3% 
from Chondromyces, 5.2% from Polyangium) of the total number of myxobacterial 
compounds (Gerth et al., 2003). The richness of natural products and the great potential 
in this suborder is also reflected in the novel isolate described in this study, Aetherobacter 
rufus SBSr003.  
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Materials and Methods 
 
Microorganism and Cultivation Condition 
The myxobacterium of interest, Aetherobacter rufus strain SBSr003, was isolated in 2007 
from a soil sample containing decaying plant material (see Aetherobacter section). This 
bacterium produces a whitish-cream colony, later developing into aggregated clusters of 
red fruiting bodies. A. rufus SBSr003 and other strains within this proposed new genus 
are noted for their unusual deep agar penetration and simultaneous yeast medium clearing 
as coherent cells glide underneath the solid medium. Due to good growth yielding high 
cell densities at the colony edges, the novel bacterial isolate was maintained in this yeast 
medium (Garcia et al., 2009b). 
 
Production 
From an actively growing agar plate culture, swarm colony edges were excised and 
inoculated into a 100 mL flask containing 50 mL medium. After 3-4 days cultivation, 
cells clumps were broken into smaller pieces by pipetting up and down several times. 
Homogenised cells were then transferred into 100 mL medium in a 300 mL flask. Pre-
culture was then obtained through 2–3 subcultivations of the homogenised cells and 
production cultivations were performed in 1L flasks containing 500mL medium and 
incubated for 1 month with constant daily medium renewal. All cultivations were 
performed in buffered yeast (bufVY/2) medium (Garcia et al., 2009a), shaken at 160rpm 
at 30°C. 
 
HPLC-MS screening 
Initial screening of A. rufus SBSr003 was performed in MD1G medium (0.35% Casitone, 
0.3% glucose, 0.05% MgSO4 · 7 H2O, 0.025% CaCl2 · 2 H2O, pH 7.0, adjusted with KOH 
before autoclaving) supplemented with 2.0% Amberlite resin XAD-16 (Sigma-Aldrich). 
At the end of the 5 d cultivation, cells and resins were harvested together by 
centrifugation (5000 rpm, 10 min) and extracted with 50 mL methanol. After the sample 
was dried by rotary evaporation, the dried extract was resuspended in 1 mL methanol. 
100 μL samples of crude extract were prepared for HPLC-MS analysis (Agilent 1100 
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Series LC coupled to Bruker HCT Plus MS). 5 uL aliquots were injected into a CC125/2 
Nucleosil C18 gravity column (ID, 3µm, Macherey-Nagel).  A constant flow rate of 0.4 
ml/min was maintained. The elution gradient using solvents A and B was as follows: 0-2 
min 5% B, 2-32 min 5-95% , 32-36 min 95% B, 36-39 min 95-5% B, 39-44 min 5% B.  
Solvent A was ddH2O with 0.1% formic acid and solvent B was acetonitrile with 0.1% 
formic acid.  Ion detection was set to alternate between positive and negative modes. 
Masses were analysed in the base peak chromatograms in positive, negative and UV 
modes.  
 
Extraction and Compound Isolation 
After the end of cultivation, cells clumps were harvested from 500 mL culture by 
pipetting and centrifugation at 5000 rpm for 10 min at 20°C. The supernatant was 
discarded and the wet cell pellet (30 mL) was defatted with 400 mL hexane followed by 
eight successive extractions using 200 mL ethyl acetate. The crude extract was then 
concentrated in vacuo by rotary evaporation. Semi-preparative separations of the ethyl 
acetate was performed in a HPLC system (Agilent Technologies) fitted with a Jupiter 
Proteo C12 250 x 10mm column, using methanol as solvent A and ddH2O with 0.05% 
triflouroacetic acid as solvent B. Using a constant flow rate of 2.5 mL/min, the extract 
was separated using the following gradient: 0 min, 50% B; 40 min, 20% B; 50 min, 5% 
B; yielding pure compound A [retention time, 40.58 min; m/z, 718.3829] and compound 
B [RT 42.94 min; m/z, 718.3829] (Fig. 4). Both compounds were isolated manually based 
on retention time and UV absorption at 220 nm and 280 nm. 
 
Biological Assays 
A standardised MTT test was done in a 96-well plate using the human colon carcinoma 
HCT-116 cell line at a density of 1 x 105 cells/mL. The cells were inoculated into 
McCoy’s medium (Gibco) containing 10% fetal bovine serum (Gibco). The pure 
compounds were prepared at a concentration of 1 mg/mL, dissolved in dimethyl sulfoxide 
(DMSO), and serially diluted (1:3) in the plate. DMSO was used as the solvent control. 
After incubation for 3 d at 37°C and 5% CO2 saturation, 5 mg/mL MTT reagent [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] dissolved in phosphate buffer 
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solution was added and the cells further incubated for 30 min under the same conditions. 
The reagent was then carefully discarded and the cells lysed with 100 µL DMSO.  The 
IC50 value was determined by measuring absorption at 590 nm using the plate reader 
(Bio-Tek Instruments, Inc., U.S.A.). 
 
An antimicrobial assay of the pure compounds was performed using a range of bacteria, 
yeasts, and mould. Gram-negative Escherichia coli 2-DC, Escherichia coli TolC, 
Pseudomonas aeroginosa, Chromobacterium violaceum, Gram-positive Staphylococcus 
aureus MRS3, Micrococcus luteus, acid-fast Mycobacterium diernhoferi, yeast Candida 
albicans, Hansenula anomala, and filamentous fungus Mucor hiemalis were used as test 
indicator strains. The bacteria were grown in EBS medium [0.5% peptone (Marcor), 
0.5% proteose peptone, 0.1% yeast extract (Difco), 0.1% meat extract (Merck), 1.0% 
HEPES, pH adjusted to 7.0 before autoclaving] while the fungi were grown in MYC 
medium [1.0% Phytone Peptone (Difco), 1.0% glucose, 50mM HEPES, pH adjusted to 
7.0 before autoclaving], and incubated for 24 h (bacteria) and 36 h (yeasts and mould) at 
30ºC. These microorganisms were adjusted to an OD600 of 0.015.  Using the Kirby-Bauer 
agar diffusion method, 20 μg/mL of the air-dried compound were impregnated on 6 mm 
sterile standard blank paper discs. Growth inhibition of the test microorganism was 
determined by measuring the diameter of the inhibition zone.  
 
Results and Discussion 
Initial screening based on a 50 mL culture containing resin XAD-16 has shown 
cytotoxicity of the crude extract against cervical carcinoma (KB3.1) and mouse fibroblast 
cells (L929) that could not be correlated to any known myxobacterial compound. The 
HPLC-MS chromatogram revealed unknown compounds [e.g. (M + H)+ 717.9344] in the 
negative mode with UV absorption at 230 nm. In addition, no known compound could be 
identified from this strain. Comparative HPLC-MS analysis of the resin and cell extracts 
revealed that the compounds of interest were bound to the latter, and isolation was 
therefore performed from cell biomass. This is not the first time that a compound from 
myxobacteria was reported as bound to the cell.  The secondary metabolite crocacin from 
Chondromyces crocatus Cm c3 was also detected in cell pellet (Kunze et al., 1994). 
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LTQ-Orbitrap high resolution analysis indicated a chemical formula of C41H54N2O9 for 
both compounds, suggesting possible isomerism. The compounds appear to belong to the 
same family, as supported by identical mass fragmentation and UV absorption patterns 
observed in HPLC-MS.  
 
From 30 mL wet cell biomass, 250 mg of yellowish crude ethyl acetate extract were 
obtained. Semi-preparative HPLC separations yielded 3.97 mg and 4.81 mg of an oily 
white substance corresponding to compounds A and B, respectively. The yield is 
unsurprising, as myxobacteria tend to initially produce low amounts (0.1 – 20mg/L) of 
secondary metabolites (Reichenbach & Höfle, 1993). In general, secondary metabolite 
production in myxobacteria can be increased through growth optimisation (Gerth et al., 
2003). As with many other myxobacteria, the production of compound families appears 
common. Sorangium exemplifies this characteristic in the biosynthesis of many 
derivatives of disorazol. Myxalamides and myxothiazols derivatives are likewise 
commonly produced by different species and genera of the Cystobacterineae suborder.  
The production of intriguing compounds by the novel isolate A. rufus reaffirms a 
previous study (Gerth et al., 2003) suggesting that Sorangiineae is one the richest sources 
of secondary metabolites in myxobacteria. 
 
 
Figure 4. Semi-preparative HPLC separation of compounds A and B.  Compounds are   
detected at 280 nm. 
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Interestingly, compounds A and B show biological activity against a human colon tumour 
(HCT) cell line, with compound A (IC50 = 81.3ng/mL) exhibiting nearly the same activity 
as compound B (IC50 = 84.8ng/mL) (Fig. 5). Myxobacteria are known for the production 
of many active compounds against eukaryotic cells, and their ability to produce these 
compounds appears to play a role in their micropredatory lifestyle, colonisation of a 
niche, and out-competition of other microorganisms (Reichenbach & Höfle, 1993). It is 
hypothesised that many of the secondary metabolites of Sorangiineae, as represented by 
the cellulose-degrading Sorangium and Byssovorax and the common wood-colonising 
Chondromyces, are produced to inhibit yeast and mould competitors on wood substrates. 
As a member of Sorangiineae suborder and closely related to other previously mentioned 
genera (Garcia et al., 2010; Garcia et al., 2011), it is clear as to why Aetherobacter is 
producing these bioactive compounds.  
 
Figure 5. Cytotoxic effect of compounds A and B against HCT-116 human colon tumour 
cells and their corresponding IC50 values. 
 
An MTT test revealed that the novel compounds were cytotoxic to some cell lines. This is 
not surprising as some myxobacterial compounds (10%) act upon the cytoskeleton 
(Reichenbach, 2001).  In U-20S human osteosarcoma cells (data not shown) and human 
fibroblasts, actin fibre remodelling, suspected to be a result of stress, was observed (Figs. 
6a-b). This activity is different from the known actin-stabilising chondramides (Sasse et 
al., 1998; Figs. 6c-d). Actin-related activity resulting from treatment with other 
myxobacterial compounds was also determined in chivosazol (Diestel et al., 2009; Irschik 
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et al., 1995) and rhizopodin (Jansen et al., 2008), produced by members of Sorangium 
and Myxococcus, respectively. Although there is no clear evidence yet as to the real target 
and mode of action of either compound, studies are on-going. The actin stress fibre effect 
observed in the treated cell lines are perhaps a secondary effect of a yet unknown 
mechanism of action. Although a mode of action could also be predicted on the basis of 
structural similarity to closely related substances, this is only possible after complete 
structure elucidation. There are no indications of antibacterial activity, as suggested by 
negative results against a panel of Gram-positive and Gram-negative bacteria; however, 
mild antifungal activity was observed in the yeast Hansenula anomala. The activity of 
the newly isolated compounds reflects the original environmental source, where there is 
stark competition and dynamic interaction for common resources. 
 
Figure 6. Effect of compound A on HSF-1 human fibroblasts as determined by 
fluorescent microscopy. Untreated control cells (a), treated cells exhibiting pronounced 
accumulation of long green fluorescent stress fibres (b), cells treated with chondramide A 
(c) and chondramide C (d). 
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Novel isolates, as represented by Aetherobacter, clearly represent a good source of new 
bioactive natural products. A recent study on a yet undescribed Sorangiineae also 
supports this hypothesis (Gawas et al., 2011). Through continuous isolation and 
screening of new isolates, novel compound discovery in myxobacteria appears far from 
exhaustion.  
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